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2Abstract
Nowadays,  very  lit t le  is  known  of  the  aet iology  of  brain  tum ours  in  adult s  and
despite all effor ts from  scient ists there is st ill a lim ited understanding of this
disease. However, previous studies suggest  that  there is associat ion between som e
genet ic and environm ental factors and adults’ brain tum ours. Risk factors that  have
been  considered  to  play  a  role  in  brain  tum ours  aet iology  are  exposure  to
elect rom agnet ic f ields (EMF), diet ,  genet ics,  ionizing radiat ion, radio frequency
exposure, occupational chem ical exposure (pest icides and solvents) , head t raum a,
viruses and it  has also been suggested that  factors such as allergies or  influenza
m ay  be im portant .  In  this study  a detailed  lit erature review  obtained for  three risk
factors;  exposure to electrom agnet ic fields (EMF) , diet  and genet ics.
The  current  evidence  on  elect rom agnet ic  fields  (EMF)  as  an  aet iological  factor  for
brain tum ours is inconclusive, exist ing data suggest  weak or no associat ion. We
have  to  consider  that  exposure  to  electrom agnet ic  fields  is  difficult  t o  m easure,
therefore exposure assessm ent ,  part icular ly  in  occupat ion set t ings,  varies from  one
study t o another .
There  is current ly  only  lim ited  data  for  the  relat ion  between  diet  and  brain  cancer
and  a  num ber  of  nut r ients  have  been  suggested  as  potent ial  r isk  factors.  One
suggested nut rient  is N-nit roso com pounds as potent ial central nervous system
(CNS)  carcinogens.   In  addit ion,  there  is  som e  evidence  of  a  protect ive  effect  of
consum pt ion  of  ant ioxidants  (vitamin  C,  vitam in  E  and  carotenoids) .  Other
nut rients and foods seem  to play a role in brain cancer include zinc and aspartame.
According to som e studies, the blood-brain barr ier  in relat ion with diet  m ight  play a
role in brain tum our genesis or t reatm ent .
3Very  lit t le  is  known  for  the  associat ion  of  genet ics  with  brain  tum ours.  Many
m utated or  altered genes,  such as p53,  Rb1,  CDKN2A,  p16I NK4A,  and CDK4,  seem
to have an involvem ent in the developm ent of brain tum ours, but  st ill t he role they
play in the form att ing of the tum our is not  ident ified. Only about 5%  of prim ary
brain  tum ours  are  known  to  be  associated  with  hereditary  factors.  Com m on
variat ions in  the  st ructure  of  specific genes are  known  to  be associated  with  basic
cellular  m etabolic processes such as oxidat ion, detoxif icat ion, DNA stability  and
repair ,  and  im mune  funct ioning.  Such  genet ic  polym orphism s  m ay  well  be
associated with the developm ent  of brain tumours in the presence or absence of
environm ental carcinogens.
To bet ter  understand the potent ial  risk  factors for  brain  cancer  a populat ion  based
case-cont rol study was conducted in four regions in the UK;  Cent ral Scot land, West
Yorkshire,  West  Midlands  and  Trent  was  established  collect ing  a  wide  variety  of
informat ion including informat ion on occupat ional sources of elect rom agnetic fields.
This  study  invest igated  the  link  between  cumulat ive  elect rom agnet ic  field  (EMF)
exposure that  reflected lifet im e exposure, rather t han elect rom agnet ic field (EMF)
exposure  from  any  specific  job  and  gliom a,  m eningiom a  and  acoust ic  neurom a.
Cumulat ive  exposure  to  elect rom agnet ic  fields  was  determined  by  generic
geomet ric means assigning to each job coded using Standard I ndust ry
Classificat ion (SI C)  and Standard Occupat ion Classificat ion (SOC) .
Data  were  obtained  from  970  cases  of  brain  tum ours  (gliom as  n= 588;
m eningiom as n= 247;  acoust ic neurom as n= 135)  and  1097  cont rols.   For  all  brain
tum our cases, exposures to elect rom agnet ic f ields est im ated using Standard
I ndust ry Classif icat ion (SI C)  in the 3 rd and 4 t h quart ile had a stat ist ically  signif icant
decreased r isk  com pared to the first  quart ile (Q3:  OR 0.73,  95%  CI  0.55-0.97  and
Q4:  OR 0.70, 95%  CI  0.52-0.94, p for  t rend 0.019) . Sim ilar  results were observed
with gliom as. No associat ion was found between exposure to elect rom agnet ic f ields
4(by SI C)  and m eningiom as or acoust ic neurom as. No stat ist ically significant
associat ions were found between exposure to elect rom agnet ic fields by Standard
Occupat ional classificat ion (SOC)  coding and brain tum ours, gliom as and
m eningiom as.  Exposure  to  elect rom agnet ic  fields  est im ated  using  SOC  was
inversely  associated  with  acoust ic neurom as (Q2:  adjusted  OR 0.53,  95%  CI  0.31-
0.90, Q3:  adjusted OR 0.52, 95%  CI  0.29-0.93) . Nevertheless, there was no clear
t rend of r isk reduct ion (p for  t rend 0.287) .
The results in this study do not  support  the hypothesis that  occupat ional exposure
to electrom agnet ic fields (EMF)  is associated with an increased r isk of brain
cancers.  I n fact , there is som e evidence of a protect ive effect  of elect rom agnet ic
fields (EMF)  exposure.  The healthy worker effect  (HWE)  m ay entail different ial bias
towards the result s,  as healthy indiv iduals gain employm ent  and remain in indust ry
and ill or  disable people not  rem ain em ployed.
Even though, several epidem iological studies were conducted invest igat ing the risk
factors of brain tum ours the result s are inconsistent . There are st ill m any
cont roversies about  the environm ental and genetic factors that  are im portant  in
the aetiology of the disease.  For  dietary factors,  further  epidem iological studies
need  to  use  data  from  a  big  sam ple  size,  being  obtained  from  food  frequency
quest ionnaires,  and  t ry  to  invest igate  the  role  that  nutr ients/ food  groups  play  in
brain tum ours. More at tent ion m ust be given in specific nutr ients, such the N-
nit roso com pounds, ant ioxidants and aspartame. I n the analysis confounders, like
age, sex, deprivat ion category, and energy intake, must  be adjusted.
The evolut ion of genetic epidemiological m ethods we face in the last  years increase
the am ount  of  inform at ion for  genet ics and invest igators need to focus on the data
m anagem ent  and analysis of  these outputs.  Large-scale subjects m ust  be designed
in order  to invest igate candidate genes (p53,  Rb1,  CDKN2A,  p16I NK4A,  and CDK4)
5and genetic polym orphism s and their  associat ion with brain tum ours. A new
approach of studying gene-environm ental interact ion should be considered with
at tent ion, as it  might  be the direct ion of the future.
Finally,  for  elect rom agnet ic fields further  studies m ust  be carried out ,  with detailed
com plex  job-exposure m atr ixes (JEMs)  that  will  t ake into account  specific job  t it le,
descript ion  of  the  tasks  each  worker  is  perform ing,  workplace,  accurate  t ime  of
working  and  even  direct  m easurem ents  of  exposure  with  individual  dosim eters.
Bet ter  classificat ion  of  jobs  m ust  be  done  and  cases  with  high  illness  must  be
included in our sam ple size, in order to achieve m ore accurate and precise result s.
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91 . I nt roduct ion
This chapter describes the pathology of brain tum ours and their  classificat ions. I t
then int roduces the incidence and mortalit y  of brain tum ours. I t  is followed by a
report  of  epidemiological  studies  invest igat ing  r isk  factors  for  brain  tum ours;  in
part icular  it  focuses  on  the  potent ial  risk  factors  of  elect rom agnet ic  fields  (EMF) ,
diet  and genetics.
1 .1  Pathology of bra in tum ours
The  Central  Nervous  System  (CNS)  consists  of  the  brain  and  the  spinal  cord.  The
brain  is  m ade  up  of  the  cerebrum ,  the  cerebellum  and  the  brain  stem  (DeAngelis
LM 2001) .  The  cerebrum  is  the  largest  part  of  the  brain  and  it  is  subdivided  into
four  lobes (frontal lobe, par ietal lobe, tem poral lobe, occipital lobe) .  The cerebellum
located  at  the back  part  of  the brain,  beneath  the cerebrum .  The brain  stem  is the
port ion  of  the  brain,  which  is  connected  to  the  spinal  cord  and  it  is  com posed  by
the  pons,  m edulla,  and  m idbrain.  The  central  st ructures  of  the  brain  are  the
thalamus,  hypothalam us,  and  pituitary  gland.  The  vent r icles  are  natural  cavit ies
inside  the  brain  filled  with  cerebrospinal  f luid.  The  meninges,  which  are
m em branes,  surround  the  brain  and  the  spinal  cord  and  are  responsible  for  their
protect ion. (www.cancer.net ,  accessed  28  April  2009) .  These  m ajor  areas  of  the
brain are illust rated in figure 1.
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         Figure 1 . The m ajor areas of the brain
( Picture found in www.medem.com/medlib/article/ZZZYUAM46JC ,  accessed 2 8
April 2 0 09 ) .
The term  brain cancer refers to any of a var iety of tum ours affect ing different  brain
cell  t ypes.  An  abnorm al  and  uncont rolled  growth  of  cells  creates  an  int racranial
m ass  called  as  brain  tum our  (DeAngelis  LM.  2001) .  These  cells  either  norm ally
found in the brain it self:  neurons, glial cells (ast rocytes, oligodendrocytes, and
ependym al  cells) ,  lym phat ic  t issue,  blood  vessels) ,  in  the  cranial  nerves  (m yelin
producing cells Schwann cells) ,  in the brain envelopes (meninges) ,  skull,  pituitary
and pineal gland, or spread from  cancers prim arily located in other organs
(m etastat ic  tum ours)  (DeAngelis  LM.  2001) .  Although  they  can  affect  any  part  of
the  brain,  brain  tum ours  are  com m only  located  in  the  posterior  cranial  fossa  in
children and in the anterior  two- thirds of the cerebral hem ispheres in adult s
(DeAngelis LM.2001) .
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        Classif icat ion of brain tumours
The brain tum ours norm ally  ar ise from  cells present  in  the brain it self  and they  are
either benign or  malignant .  I n cont rast  to tum ours originat ing elsewhere in the
body,  even  benign  brain  tum ours  tend  to  t ransform  into  m alignant  form s
(DeAngelis  LM.  2001) .  Som e  types  of  brain  tum ours,  as  m eningiom as  and
lym phom as,  do  not  arise  from  the brain  t issue (DeAngelis LM.2001) .  Meningiom as
arise from  the meninges and lym phom as, which is a form  of a cancer that  begins in
the lym phat ic system , star ts in the brain and can spread to the spinal fluid and
eyes (www.cancer.net  accessed 28 April 2009) .
There is a histologically classificat ion of brain tum ours depending on the part  of the
brain  that  each  tum our  arises.  The  m ost  frequent ly  reported  histology  is  a  non-
m alignant  brain tum our, m eningiom a, which accounts 33.4%  of all brain tum ours.
I t  is  followed  by  gliom as,  brain  tum ours  that  arise  from  glial  cells,  represent  30%
of all brain tum ours and 80%  of m alignant  brain tum ours. The non-malignant
pituitary and nerve sheath tum ours account  for  12%  and 9%  of all brain tum ours,
respect ively. Acoust ic neurom as account  for 60%  of all nerve sheath tum ours.
Lym phom as  represent  2.5%  of  all  brain  tum ours.  There  are  also  several  types  of
brain  tum ours  which  account  for  a  very  sm all  percentage  of  all  brain  tum ours.  All
these types represent  12.4%  of all brain tum ours. The distr ibut ion by histology is
shown in Figure 2.
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Figure 2 . Distr ibut ion of brain tum ours by histology ( CBTRUS Stat ist ical
Report  20 07 - 2 00 8 ) .
As m ent ioned above,  gliom as are one of  the m ost  prim ary  brain tum ours.  They  are
originat ing  from  glial,  a support ive cell  in  the brain:  ast rocytes (ast rocytom as)  and
oligodendrocytes (oligodendrogliom as)  (Houben 2006) . Astrocytes provide
st ructural support  for  neurons and m aintain elect rolyte and neurotransmit ter
hom eostasis in  the brain.  A role in  the physical  and chemical  integrity  of  the blood
brain  barrier  is  played  from  astrocytes  and  ependym al  cells  (www.cancer.net
accessed 28 April 2009) .  Ast rocytom a is one the m ost  com m on type of  gliom a and
begins in cells called ast rocytes in the cerebrum  or the cerebellum  (DeAngelis LM.
2001) .  There are three m alignancy  grades of  ast rocytom as,  according to the World
Health  Organisat ion  (WHO)  (Kleihues  et  al  2000) ,  grade  I I  ast rocytom a,  grade  I I I
anaplast ic ast rocytoma and grade IV glioblastoma mult iforme, based on several
pathological cr it eria such as cellularity ,  nuclear  atypia,  mitosis,  m icrovascular
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proliferat ion and necrosis. Astrocytom as account  for a 7.4%  of all brain tumours
and for a 22.6%  of all gliom as (CBTRUS Stat ist ical Report  2007-2008) .
Glioblastom a is a m alignant  ast rocytom a that  contains areas of  dead tum our  cells.
Approxim ately  50%  of  ast rocytom as  are  glioblastom as  (Kleihues  et  al  2000) .
Glioblastom as  t ypically  contain  m ore  than  one  cell  t ype.  While  one  cell  type  m ay
die  off  in  response to  a  part icular  t reatment ,  the  other  cell  types m ay  cont inue to
m ult iply.  This  characterist ic  m akes  glioblastom as  very  difficult  t o  t reat
(www.cancer.net  accessed 28 April 2009) . Glioblastom as  represent  the  17.6%  of
all  brain  tum ours  and  the  54%  of  all  gliom as  (CBTRUS  Stat ist ical  Report  2007-
2008) .
Oligondedrogliom a is a tum our that  develops from  cells called oligodendrocytes.
Oligodendrocytes produce and m aintain myelin in the central nervous system  and
ependym al cells form  the endothelium  that  lines the vent ricles of the brain and the
cent ral canal of the spinal cord (DeAngelis LM. 2001) .  In oligodendrogliom a only
two malignancy grades are dist inguished, WHO grade I I  oligodendrogliomas and
grade I I I  anaplast ic oligodendrogliomas (Kleihues et  al 2000) . Oligodendrogliomas
represent  2.1%  of  all  brain  tum ours  and  6.6%  of  all  gliom as  (CBTRUS  Stat ist ical
Report  2007-2008) .  There  are  also  mixed  form s,  with  both  an  ast rocyt ic  and  an
oligodendroglial cell com ponent .  These are called m ixed gliom as or
oligoastrocytom as. Addit ionally, m ixed glio-neuronal tumours ( tum ours displaying
a neuronal,  as well as a glial com ponent ,  e.g.  gangliogliom as, disem bryoplast ic
neuroepithelial tum ours)  and tum ours or iginat ing from  neuronal cells (e.g.
gangliocytom a,  cent ral  gangliocytom a)  can  also  be  encountered  (Houben  2006) .
The dist ribut ion of all gliom as by histology subtypes is illustrated in f igure 3.
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Subtypes
Glioblastoma
53%
All other Glioma
11%
All other
astrocytoma
9%
Anaplastic
Astrocytoma
6.8%
Protoplasmic&
Fibrillary
Astrocytoma
1.6%
Pilocytic
astrocytoma
5.2%
Oligodendroglioma
6.6%
Ependynoma
5.8%
Figure 3 . Distribut ion of all gliom as by histology subtypes ( CBTRUS
Stat ist ical Report  2 00 7 -2 0 08 ) .
True benign int racranial tum ours ar ise m ainly from  the m eninges (m eningiom as;
about  90%  are  benign) ,  pituitary  gland  (pituitary  adenom as)  and  the  myelin
sheath of cranial nerves (neurom as or  Schwanom as, e.g. acoust ic neurom a)
(DeAngelis  LM.  2001) .  Meningiom as  const itute  approxim ately  33.4%  of  brain
tum ours and norm ally  form  on  the surface of  the brain.  They  can  cause significant
sym ptom s  if  they  grow  and  press  on  the  brain  or  spinal  cord  or  invade  into  the
brain  t issue.  The  m ajority  of  m eningiom as  grow  slowly  and  characterised  by  the
loss of  the chrom osom e 22q (DeAngelis LM.  2001) .  Pituitary  gland tum ours are not
brain  tum ours,  as  this  gland  sit s  beneath  and  separate  from  the  brain,  but  can
cause serious symptoms in other organs or system s. Generally, they are benign
but  som et im es can show m alignant  behaviour.  A rare t ype of tum our is the
acoust ic neurom a, which begins in the vest ibular  nerve (a nerve in the inner ear
that  helps cont rol balance) ,  and is norm ally benign (www.cancer.net , accessed 28
April 2009) .
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Other var iet ies of pr im ary brain tum ours include:  prim it ive neuroectoderm al
tumours (PNET, e.g. medulloblastom a, medulloepitheliom a, neuroblastom a,
ret inoblastom a,  and  ependym oblastom a) ,  tum ours of  the  pineal  parenchym a (e.g.
pineocytoma, pineoblast om a), ependymal cell t umours, choroid plexus tumours,
neuroepithelial t um ours of uncertain origin (e.g.  gliom atosis cerebr i,
ast roblastom a) , etc. (DeAngelis LM. 2001, Kleihues et  al 2000) .
Sym ptom s and Diagnosis
The  sym ptom s  brain  tum ours  cause  are  either  focal  or  generalised  neurogical
(Houben  2006) .  Focal  sym ptoms are norm ally  hem iparesis and aphasia and reflect
the int racranial locat ion of the tum our. The generalised sym ptom s that  occur,  such
as headache, nausea vom it ing and visual complaints, are the result  of the
increased int racranial pressure (DeAngelis LM. 2001) .
The diagnosis of brain tum our relies on m odern neuroim aging techniques.
Therefore, the cranial m agnetic resonance im aging (MRI )  with gadolinium
enhancement  is the test  which can establish easily  the diagnosis (DeAngelis LM.
2001) .  I f  we  want  to  obtain  t issue  for  histopathological  diagnosis,  after  MRI ,  a
biopsy or surgical decom pression must  be followed (Houben 2006) .
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1 .2 Epidem iology of bra in tum ours
I ncidence and m ortality:
Nowadays,  the  incidence  of  brain  tum ours  appears  to  be  on  the  rise,  especially  in
developed count r ies. I mproved diagnost ic techniques at tempt  to provide the
reason  for  these  large  scale  changes.  According  to  the  stat ist ical  report  of  the
Central Brain Tum our Regist ry of the United States (CBTRUS)  and the Internat ional
Agency  for  Research  on  Cancer  ( I ARC)  the  worldwide  incidence  rate  of  prim ary
malignant  brain tumors, age-adjusted using the world standard populat ion, is 3.7
per 100 000 persons-years in m ales and 2.6 per 100 000 persons-years in fem ales.
The incidence rates are higher in m ore developed count ries (m ales:  5.8 per 100
000 persons-years, fem ales:  4.1 per 100 000 persons-years)  than in less
developed count ries (m ales:  3.0  per  100  000  persons-years,  fem ales:  2.1  per  100
000 persons-years) .  (CBTRUS Statist ical Report  2007-2008) . Official crude
incidence for  brain tum ours in Great  Britain is approximately 7 per  100,000, or
4000 new cases per year. I n Great  Britain, brain t um ours are the 8 t h comm onest
m alignancy in adults under 65 and in adult s under 45s the fourth most  comm on
(Black  et  al  1993,  Sharp  et  al  1993) ,  em phasizing  the  im portance  in  the  working
populat ion. I n Scot land the 10.7%  of all registered cancer deaths in under-45s
were at t ributed to brain tum ours (Grant  et  al 1996) . An increase in incidence has
been  observed  in  parts  of  the  UK (Sharp  et  al  1993)  and  elsewhere  in  the  world,
including  Western  Europe  and  the  US  (Polednak  1991,  Davis  et  al  1990) .  Most
studies suggest  that  the r ise is not  artefactual,  even though advances in diagnost ic
techniques m ay account  for a proport ion of the increase, part icularly in the elder ly.
I n  2007,  in  the  UK there  were 3,611  deaths from  brain  and  other  cent ral  nervous
system  cancers,  which  accounted  for  just  over  2%  of  all  cancer  deaths  (Office  of
Nat ional Stat ist ics, Mortalit y Stat ist ics, England and Wales 2007, accessed
February  2009) .  The  m ortalit y  rate  in  Great  Britain  is  5.0  per  100  000  persons-
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years.  The  m ortality  rate  is  higher  am ong  m ales  (6.1  per  100  000  m ales-years)
than  am ong  fem ales  (4.0  per  100  000  fem ales-years)  (The  Office  of  Nat ional
Stat ist ics, Mortalit y Stat ist ics, England and Wales 2007, accessed February 2009) .
A  previous  study  of  cancer  m ortalit y  in  England  and  Wales  ident if ied  Cent ral
Nervous System  (CNS)  tum ours as one of the cancers showing a rem arkable r ise in
m ortalit y,  as the  rates rose m ore than  sixfold  between  1950  and  1989  (Coggon  &
I nskip 1994) .
1 .3  Risk factors of brain tum ours
1 .3 .1  Elect ro Magnet ic Fields
The associat ion  of  brain  tum ours and exposure to elect rom agnet ic fields (EMF)  has
been a m ajor concern and several studies were conducted to examine the role that
the exposure to elect rom agnet ic fields might  play in this disease.
I ntroduct ion to e lectrom agnet ic fields
Magnet ic  and  electr ic  fields  are  both  associated  to  elect ric  current  f low  and  the
term  elect rom agnet ic  fields  (EMF)  is  com m only  referred  to  both  (WHO  -World
Health  Organizat ion,  2006) .  Magnet ic  fields  (MF)  ar ise  from  elect r ic  current  flows
and  Elect ric  f ields  (EF)  from  voltage  and  exist  even  when  there  is  no  current  flow
(Marcílio et  al,  2009) .  Elect rom agnetic f ields generated by different  sources, either
natural ( solar  radiat ion and ult raviolet  light )  or  hum an-m ade ( radiowaves and
elect ric  power)  (WHO  -World  Health  Organizat ion,  2006) .  The  st rength  of  the
Electr ic f ield is m easured in Volts per m et re (V/ m )  and the st rength of the Magnet ic
field  in  Am peres per  m etre (A/ m ) .  Elect rom agnet ic fields (EMF)  invest igators use a
related m easure, f lux density ( in m icrotesla (µT)  or m illitesla (m T)  instead (Marcílio
et  al, 2009) . The frequency of electrom agnet ic fields (EMF)  m easured in Hertz (Hz)
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and size of  waves.  Direct  current  or  stat ic fields have 0  Hz frequency,  which  is the
lower  end of  the frequency  spectrum .  I onizing  radiat ions –X- rays,  Gam a rays,  and
ult raviolet  light  -  with frequency above  Hz  are  the  upper  end.  Low  frequency
fields  occupy  the  range  from  3  to  3,000  Hz,  with  long  wavelength.  Extrem ely  low
frequency  elect rom agnet ic  fields  are  ranging  between  50  Hz  and  60Hz  (CEA  -
Canadian Electr icit y  Associat ion. 2006) .
Biological Mechanism s
The only established m echanism  of act ion of ext remely low frequency m agnet ic
fields (ELF MF)  is the interact ion  of  these fields with  t issues of  the hum an  body  by
inducing weak  elect ric currents in  them  (Marcílio et  al,  2009) .  These fields are also
known as “non- ionizing radiat ions”  and they cannot  break any chemical bonds
(Ahlbom  et  al 2003) . The  nervous  system  works  by  elect ric  st im ulat ion  and  it
seem s to be susceptible to the effects of t he magnet ic fields (WHO –World Health
Organizat ion, 2007) . Even though the elect r ic currents induced by ext rem ely low
frequency  m agnet ic fields (ELF MF)  are weaker  than  the ones physiologically  occur
in the hum an body, there are evidence suggest ing that  these currents m ay
increase the funct ional elect ric act ivity in the cent ral nervous system  (CNS)
(Saunders et  al 2007, WHO –World Health Organizat ion, 2007) . From  studies which
conducted there is no evidence that  ext rem ely low frequency elect rom agnet ic fields
have enough energy  to break  DNA bonds or  cause a carcinogenic process (Poole et
al.  1996, Ahlbom  et  al.  2001) . Only exposure equal or above 100 ┢T seem s to have
an adverse health effect  (Kheifets et  al. 2005) . Even if experim ental studies have
not  been  able  to  establish  any  biological  m echanism  explaining  the  interact ion  of
ext rem ely low frequency m agnet ic fields and the hum an body, there m ust  be one
since there is evidence from  epidemiological studies showing that  this exposure
m ay have an adverse health effect  (WHO –World Health Organizat ion, 2007) .
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Occupat ional exposure assessment
The m ajor  problem  that  epidemiological studies faced at tempt ing to invest igate the
associat ion between brain tum ours and exposure to elect rom agnet ic fields (EMF)  is
the  assessm ent  and  quant ificat ion  of  the  exposure  (Ahlbom  et  al  2001,  Feycht ing
et  al 2005, WHO –World Health Organizat ion 2007) .  This diff iculty  calculat ing the
exposure is due to the fact  that  we have not  indent ified a specific m ethod to
est im ate the accurate exposure to electrom agnet ic fields. Exposure to
elect rom agnet ic fields is com plex,  as it  is generated  from  several  sources,  and st ill
it  is not  found an established m ethodology to add-up these exposures in one total
exposure (Ahlbom  et  al 2001, WHO –World Health Organizat ion 2007) .  I n addit ion,
difficult ies  ar ise  for  the  definit ion  of  the  induct ion  period  to  elect rom agnet ic  fields
(Ahlbom  et  al  2001) .  All  t hese  are  obstacles  to  establish  relevant  param eters  for
the quant if icat ion of  the exposure to elect rom agnet ic fields and m ake m ore difficult
the  assessm ent  of  the  effects  of  this  exposure  to  brain  tum ours  (Ahlbom  et  al
2001, WHO –World Health Organizat ion 2007) .
Most  of the studies conducted focus in the occupat ional exposure assessm ent ,  as
elect rom agnet ic fields intensity in cer tain jobs, for  instance, can reach much higher
levels than in resident ial exposure (Ahlbom et  al 2001) . Est im at ion of the
occupat ional  exposure  can  be  obtained  with  job  categories  calendars  or  m ore
com plex  m at rices  of  exposure  (Marcílio  et  al  2009) .  Another  way  is  a  detailed
assessm ent  of  a  sam ple  of  workers  through  personal  dosim eters  (Ahlbom  et  al
2001) .
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Epidem iological studies
Studies have examined the possible associat ion between brain tum ours and
exposure  to  ext rem ely  low  frequency  m agnet ic  fields  (ELF  MF) .  Nichols  and
Sorahan (2005) ,  in  their  cohort  study  of  UK elect ricit y  generat ion and t ransm ission
workers, found significant  excesses of deaths from  brain cancer in m ale workers
from non-operat ional locat ions (Observed-Obs:  55, Expected-Exp:  36.0,
Standardized  Mortalit y  Rat ios-SMR:  153) ,  but  previous studies in  the  UK found  no
associat ion  between  increased r isk  of  brain  tumour  and exposure to ext rem ely  low
frequency magnet ic fields (ELF MF)  in the power generat ion and supply indust ry
(Harrington  et  al.,  1997;  Sorahan  et  al.,  2001) .  In  2002,  I ARC  reviewed  the
evidence of carcinogenicity  of extrem ely low frequency elect ric and m agnetic f ields
(ELF MF)  and concluded that  ELF MF exposure are possibly carcinogenic to humans,
although this was predom inant ly based on evidence from  resident ial exposure and
childhood leukaem ia studies. This evidence suggests that  resident ial exposure to
ext rem ely  low  frequency  electrom agnet ic  fields  might  play  a  role  in  the
carcinogenesis of childhood leukaemia ( IARC Working Group on the Evaluat ion of
Carcinogenic Risks to Hum ans, 2002) .
One  of  the  hypotheses  of  the  UK  Adult s  Brain  Tum our  Study  (UKABTS)  is  to
evaluate the associat ion between exposure to ext rem ely low frequency m agnet ic
fields  (ELF MF)  and  brain  tum ours  risk.   This  study  found  evidence  that  elect r ical
work  am ongst  m ales  was  associated  with  an  increased  r isk  of  developing  gliom a
(Odds Rat io 1.4, 95%  CI  0.9-2.0)  ( van Tongeren et  al. ,  2007) . Although increase
r isk is not  stat ist ically  signif icant  in this study it  shows that  invest igat ions for
f inding an associat ion between elect rom agnet ic f ields and brain tum ours are in the
r ight  direct ion.  The result s were in  keeping  with  other  studies (e.g.  Preston-Mart in
et  al. ,  1993;  Loom is and Savitz, 1998;  Thom as et  al.,  1987;  Zheng et  al 2001) .
The strongest  r isks were shown in Preston-Mart in et  al studies invest igat ing
21
exposure to elect rom agnet ic f ields and the r isk of brain tum ours am ong elect r icians
(OR 4.6, 95%  CI  1.7-12.2)  and electr ical engineers (OR 8.2, 95%  CI  20-34.7) ,
even  though  increase  risks  are  not  stat ist ically  significant  (Preston-Mart in  et  al
1993) . Loom is and Savit z study found that  increasing cum ulat ive m agnet ic f ield
exposure  was  associated  with  increasing  m ortalit y  in  brain  tum ours  pat ients,  with
rate rat ios (RR):  1.3-3.4 for  the m ost  exposed workers (Loomis and Savitz 1998) .
A case cont rol study of brain tum ours and occupat ional r isk factors in northern New
Jersey  shown elevated relat ive risk  (RR)  for  all brain tum ours am ong m en exposed
to m icrowave and radiofrequency  (MW/ RF)  radiat ion (RR 1.6;  95%  CI  1.0-2.4)  and
was  significant ly  elevated  am ong  m en  exposed  for  20  or  m ore  years.  Also,  this
study  showed  an  increase  r isk  of  developing  brain  tum our  am ong  elect rical  or
elect ronic workers (RR =  2.3;  95%  Cl =  1.3-4.2)  (Thomas et  al 1987) . In Zheng et
al  case  cont rol  study  a  significant ly  increase  risk  was  obtained  for  em ploym ent  of
m ore  than  10  years  in  occupat ions  or  indust r ies  with  elect r ic  or  elect ronic
equipm ent  (Zheng et  al 2001) .
Lit t le  is  known  about  occupat ional  ext rem ely  low  frequency  m agnet ic  fields  (ELF
MF)  levels  outside  this  indust ry  sector  in  the  UK,  even  though  in  the  power
generat ing  and  dist ribut ing  industry  there  is  relat ively  abundance  of  ELF  MF
exposure inform at ion (Merchant  et  al.,  1994;  Renew et  al,  2003) .   The study  team
therefore  designed  a  study  within  the  UKABTS  project  to  collect  extrem ely  low
frequency  m agnet ic  fields  (ELF  MF)  m easurem ents  on  a  subset  of  the  UKABTS
part icipants ( van Tongeren et  al 2004, Mee et  al 2006) . I nform at ion on occupat ion,
tasks  and  use  of  equipment  was  obtained  during  interviews  using  Com puter
Assisted  Personal  Interview  (CAPI )  software  (van  Tongeren  et  al  2004) .  Addit ional
data were collected with Em dex I I  m agnetic fields meters (Enertech Consultants
Ltd,  California,  USA) .  Individuals  who  agreed  to  part icipate  were  wearing  the
m eters  at  the  waist  and  left  them  at  the  bedside  overnight  (Mee  et  al  2006) .
Exposure  data  were  downloaded  using  EMCALC  software  and  t im e  weighted
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average (TWA) ,  standard  deviat ion  (SD) ,  geomet ric m ean  (GM)  and  other  m etr ics
were  com puted  (van  Tongeren  et  al  2004) .  Result s  from  a  feasibilit y  study
supported that  it  is possible t o collect  occupat ional exposure data from part icipant s
at  a  m oderate  cost  (van  Tongeren  et  al  2004) .  For  exam ple,  welding  and  working
near high voltage cables were associated with an elevated level of exposure. There
were  some  suggest ions  that  ext rem ely  low  frequency  m agnet ic  fields  (ELF  MF)
exposure  during  other  tasks,  such  as  high  current  wires,  power  stat ions,  m otors
and elect r ical t ransport , were also increased, although this was not  stat ist ically
significant ,  as  com pared  to  welding  and  working  near  high  voltage  cables  (van
Tongeren et  al.,  2004) .  In  an art icle by  Mee et  al (2006)  there is a suggest ion that
using inform at ion on tasks and working environm ent  could im prove any exposure
m odels (Mee et  al 2006) .
1 .3 .2  Diet
Lim ited  data  exist  regarding  associat ions between  diet  and  brain  tum ours.  I n  view
of  the  few  studies done,  we cannot  say  for  certain  which  nut rients are  responsible
for an increased or reduced r isk;  however an associat ion between brain tum ours
and diet  is suggested.  There are several nut rients or  food groups that  are assumed
to play  a role in  brain  tum ours.  N-nit roso,  ant ioxidants ( fruit ,  vegetables,  zinc etc)
and aspartam e are the m ost  im portant .
         N -nit roso com pounds:
One  of  the  hypotheses  that  have  been  previously  form ulated  is  that  N-nit roso
com pound (NOC)  synthesis is involved in the pathogenesis of brain tumours (Burch
et  al  1987,  Ahlbom  et  al  1986,  Tedeshi-Blok  et  al  2006,  Preston-  Mart in  and  Mack
1991, Inskip et  al 1995, Giles 1997, Pereira and Koifm an 2001) , even though som e
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studies failed to dem onst rate an associat ion (Steindorf et  al 1994, Ryan et  al 1992,
Lubin et  al 2000, Chen et  al 2002) .
N-nit roso com pounds and, specifically, certain nit rosamides and nit rosam ines result
from  react ions in the stom ach involv ing nit rites, am ides and amines present  in the
diet  ( I nskip  et  al  1995) .  High  levels  of  nit r it e  can  be  found  in  bacon  and  other
cured m eats,  f ish,  cheese,  baked goods and cereals (Howe et  al  1986,  I nskip  et  al
1995) .  Another  source of  nit r it e is the dr inking water  (Walker  et  al 1975,  MØller  et
al 1989) .  Also vegetables contain nit rit es, but  due to the fact  that  vegetables also
contain  Vitam in  C  and  E  the  nit rosat ion  process  is  blocked  (I nskip  et  al  1995) .
There  is  a  lack  of  knowledge,  even  though,  for  the  biological  m echanism  that
occurs so the N-nit roso com pounds reach the brain. The nit rosat ion process can
occur outside the stom ach too, through cell pathways involving endothelial cells
and  som e  neurons  (Leaf  et  al  1989) .  Certain  alkylat ing  agents,  such  as  ethyl  and
m ethyl  nit rosurea,  are  able  to  cross  the  blood-brain  barrier  and  due  to  their
m utagenic  potent ial  can  play  a  role  in  the  carcinogenic  process  (McKinney  P  A
2004) .
The produced result s from  the epidem iological studies invest igat ing the associat ion
of N-nitroso com pounds with brain tum ours are m ixed and inconclusive. A study
that  had taken place in United States showed that  wom en whose diets were r ich in
nit rit es  had  an  increased  risk  of  having  a  child  who  would  later  develop  brain
tum ours (Preston-Mart in et  al 1996) .  Burch et  al (1987)  reported significant ly
elevated  risks  for  salted,  pickled,  and  sm oked  fish,  but  not  for  processed  meats
(Burch  et  al  1987) .  The intake of  processed meat ,  such  as cooked ham ,  processed
pork,  and fried  bacon,  was significant ly  associated  with  an  increased r isk  of  gliom a
(Boeing  et  al  1993) .  In  a  case-cont rol  study  carr ied  out  in  Melbourne  increased
odds  rat io  (OR)  were  observed  in  m ales  who  consum ed  high  levels  of  bacon,
corned  m eats,  apples,  melons  and  oil (Giles et  al 1994) .  Nit rate levels in dr inking
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water have been invest igated and produced increase risk of developing brain
tum ours (Burch et  al 1987) ,  although a study  in Germ any failed to dem onst rate an
associat ion  (Steindorf  et  al  1994) .  An  internat ional  case-cont rol  study  by  Terry  et
al  (2009)  found  no  associat ion  for  cured  m eat ,  but  non-  cured  m eat  seem  to  be
associated with a m odest  increase glioma r isk (OR, 1.3;  95%  CI , 1.0–1.7, p for
t rend =  0.01)  (Terry et  al 2009) .
 No associat ion was found with nit rosamines or  high-nit rate vegetables,  nit rate and
nit rite in another study by Chen et  al (2002)  in eastern Nebraska. A study by Lubin
et  al  (2000)  in  I srael  showed  no  increased  r isk  as a  result  of  consum pt ion  of  food
containing  nit rates  or  nit r it es.  Prelim inary  result s  from  individual  centres  do  not
suggest  a  significant  role  for  exposure  to  N-nit roso  com pounds (Ryan  et  al  1992) .
Dietary sources are current ly being invest igated in a mult i- cent re case-cont rol
study co-ordinated by the I nternational Agency for  Research on Cancer ( IARC) .
Ant iox idants ( fruit , vegetables, vitam ins, zinc)
The “ant ioxidant  hypothesis”  is another formulated hypothesis suggest ing that
ant ioxidant  nutr ients  such  as  vitamin  C,  vitam in  E,  carotenoids  and  zinc  are
involved with  an  inverse disease associat ion  (Stanner  et  al  2004,  Chen  et  al  2002,
Hu et  al 1999, Pereira and Koifm an 2001, Preston-Mart in 1989, Vallee 1993, Ho
2002) .  A study  by  Lubin et  al (2000)  didn’t  show any  protect ive effect  at t r ibuted to
consum pt ion of fruit s and vegetables.
There is a suggest ion that  ant ioxidant  nut rients such as vitam ins C and E and
carotenoids  are  protect ive,  as  they  reduce  oxidat ive  dam age  (Bondy  et  al  1991,
Stanner et  al 2004) . Also, vitamins block the nit rosat ion process and this is m ight
be  a  reason  of  being  protect ive  ( Inskip  et  al  1995) .  I n  anim al  studies,  Vitamin  E
seem s to play  a role for  the good funct ion  of  brain  cells,  as vitamin  E deficiency  is
linked  with  increased  form at ion  of  oxygen  radicals (LeBel  et  al  1989) .  Carotenoids
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m odulate  DNA  repair  and  have  ant ioxidant  (Ast ley  et  al  2004]  and  ant i-
inflam m atory act ion (Quasim   et  al 2003, Chew 2004) .
Som e results of epidemiological studies are com pat ible with the ant iox idant
hypothesis.  An internat ional case-control study  by  Terry  et  al (2009)  found inverse
associat ion between som e vegetable groups, especially yellow-orange vegetables,
and gliom a r isk.  Another  study  by  Chen et  al (2002)  in  eastern Nebraska observed
inverse disease associat ions for intake of dark yellow vegetables (OR:  0.6, p t rend:
0.03)  and beans (OR:   0.4, p t rend:   0.0003) ,,  pro-vitam in  A carotenoids (OR:   0.5,
p t rend:   0.005) , a-carotene (OR:  0.5, p t rend:   0.01) , dietary fibre (OR  0.6, p t rend:
0.048)  and fibre from  beans (OR:  0.5, p t rend:   0.0002) . However, no associat ion
was found with vitamin C and E, dietary fibre from  grain products or fibre from  fruit
and vegetables. A study conducted in United states showed that  wom en who took
vitamins  (A,  C,  E)  had  an  inversely  related  risk  of  having  a  child  with  a  brain
tumour (OR:  0.54;  CI  0.39-0.75)  (Preston-Mart in et  al 1996) . A case-cont rol study
by Hu et  al (1999)  in Northeast  China showed that  consum ption of fresh vegetables
(OR 0.29) ,  specifically  Chinese  cabbage  and  onion,  fruit  (OR 0.15) ,  fresh  fish  (OR
0.38)  and  poult ry  (OR 0.16) ,  was  inversely  related  to  the  r isk  of  brain  tum our.  A
protect ive  effect  was  also  seen  for  vitam in  E  intake,  calcium ,  beta-carotene  and
vitamin  C  (Hu  et  al  1999) .A  study  by  Lubin  et  al  (2000)  in  I srael  showed  no
protect ive effect  at t r ibuted to consum pt ion of fruit s and vegetables.
Zinc,  due  to  its  ant ioxidant  propert ies,  can  be  protect ive  against  brain  tum ours
developm ent  (Blowers  et  al  1997) .  Zinc  is  im portant  for  DNA  replicat ion,  protein
synthesis and metabolism  (Vallee 1993) ,  oxidat ive st ress protect ion (Stehbens
2003)  and  DNA repair  (Bourre  2006) .  In  anim al  studies,  zinc  found  to  play  a  role
for  the  good  funct ion  of  neurons  and  glial  cells  (Bediz  et  al  2006,  Warm ing  et  al
2006,  Colvin  et  al  2000,  Takeda et  al 1994) .  In  a  case-cont rol  study  conducted  in
Trent ,  West  Midlands, West  Yorkshire and cent ral Scot land a stat ist ically  significant
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r isk  reduct ion  for  meningiom a was observed  only  in  the  3rd quart ile  of  dietary  zinc
(Zn)  intake (OR 0.62, 95%  CI  0.39-0.99, p= 0.048)  and  was  not  significant  after
also  adjust ing  for  intake of  other  elements.  Overall  t here  was no  significant  effect
of Zn intake therefore the specific hypothesis on a protect ive effect  of increased
com pared with low levels of dietary Zn against  gliom a or  m eningiom a format ion is
not  supported. (Dimit ropoulou et  al 2007) .My involvem ent  in this study was the
data enter ing and som e literature review.
Aspartame:
The  low-calorie  sweetener  aspartame  has  been  com m only  used  in  a  num ber  of
food products for over 15 years.  I t  has been suggested, pr incipally from  laboratory
experim ents,  that  it  is involved in the aet iology  of  som e brain tum ours (Janssen et
al 1998) .   I n  addit ion,  it  has have suggested that  it  may  be one of  the cont r ibut ing
factors in the increasing rate of cent ral nervous system  tum ours in Western
societ ies  (Olney  et  al  1996) .   The  way  in  which  aspartam e  influences  the  brain
tum our r isk is unclear;  it  is possible that  alt erat ion of the blood-brain barr ier occurs
or  that  once  ingested,  aspartam e  becom es  nit rosated,  and  thereby  m ay  be
carcinogenic  (Shephard  et  al  1993,  Yokogoshi  et  al  1984) .  The  possibilit y  that
aspartam e m ay be a cause of  brain cancer  in  hum ans was im plied in the Gurney  et
al (1997)  study, but  no relat ion was found.
Diet  literature review  sum m ary and potent ia l areas of bias
I n sum m ary, results from  epidem iological studies invest igat ing the role of diet  in
brain tum ours are inconsistent . Many hypotheses were formulated in relat ion t o
brain  cancer  and  a  range  of  nutr ients  and  foods  have  been  suggested  to  be
associated  with  the  disease.  Several  studies  support  som e  of  the  exist ing  dietary
hypotheses, suggest ing that  diet  m ight  be a risk factor  of brain tum ours (Wrensch,
2002) .
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One  of  the  hypotheses  that  have  been  previously  form ulated  is  that  N-nit roso
com pound (NOC)  synthesis has an involvem ent  in the form at ion of brain tum ours
(Burch et  al 1987, Ahlbom  et  al 1986, Tedeshi-Blok et  al 2006, Preston-  Mart in and
Mack 1991, Inskip et  al 1995, Giles 1997, Pereira and Koifm an 2001) , even though
som e  studies  failed  to  support  an  associat ion  (Steindorf  et  al  1994,  Ryan  et  al
1992,  Lubin  et  al  2000,  Chen  et  al  2002) .  The “ant ioxidant  hypothesis”  is another
form ulated hypothesis suggest ing that  ant ioxidant  nut rients such as vitamin C,
vitamin E and carotenoids have an inverse associat ion with the disease (Stanner  et
al 2003, Chen et  al 2002, Hu et  al 1999, Pereira and Koifm an 2001, Preston-Mart in
1989) .  A  study  by  Lubin  et  al  (2000)  didn’t  show  that  consum pt ion  of  fruit  and
vegetables has any protect ive effect . Besides these m ain hypotheses, som e other
nut rients,  such  as  zinc  and  aspartam e,  suggested  to  play  a  role  in  brain  tum ours
according  to other  studies (Shephard  et  al  1993,  Yokogoshi  et  al  1984,  Blowers et
al 1997, Bediz et  al 2006, Warm ing et  al 2006) .
Diet  data  can  be obtained  with  Food  Frequency  Quest ionnaires (FFQ)  and  average
daily  nutr ient  consum pt ion can be calculated by m ult iplying the daily  consum pt ion
frequency of each food item by the content  of the examined nutr ient  in t he
respect ive food item obtained from food com posit ion tables (Holland et  al 1991,
Lophatananon 2004) .
Brain tum our studies have som e problem s due to the heterogeneity in m orphology
and malignancy grade of the brain tum ours exam ined. The food frequency
quest ionnaire  (FFQ)  m ethod  consider  to  be  a  good  one,  as  it  is  cheap,  easy  to
adm inister,  and  provides  quick  intake  est im ates  (Willet t ,  1998) .  The  frequency
quest ion that  is made in the food frequency quest ionnaire usually is com bined with
a specific ‘m edium  port ion’ size and this can confuse the subjects and cause a
recall  bias (Piet inen,  1988) .  A misclassificat ion  can  be occurred  as average port ion
sizes are being  used for  the est im at ion  of  the nut rient  intake.  This might  lead to a
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loss of power of the study (Friedenreich et  al. 1993) . However, several studies
have found that  consum pt ion frequency is correlated with port ion size (Jain et  al,
1996) .
Subjects  norm ally  were  asked  to  report  their  dietary  habits  during  the  two  years
pr ior  to diagnosis,  as this period is m ore likely to overlap with the period of brain
tum or developm ent  (aet iologically relevant  period)  (Friedenreich et  al. 1993) . The
latency  period  of  the  disease  is,  generally,  undefined  (Wrensch,  2002) .  As  brain
tum our  pat ients  norm ally  suffer  from  loss  of  m em ory  and  concentrat ion,  they
m ight  response based on current  dietary  habits even if  the quest ion is for  previous
diet  (Nelson 2000, Thom pson 1994) .
A  com m on  problem  for  m any  populat ion-based  studies  is  the  low  cont rol
par t icipat ion and it  m ight  int roduce select ion bias am ongst  cont rols (Willett ,  1998) .
A potent ial source of bias can be the different ial par t icipat ion of cont rols that  have
healthy diet  habit s,  as they m ay have better  nut rit ional regimes than the general
populat ion (Fr iedenreich et  al.  1993) .  Depr ivat ion category is adjusted for  in the
analysis,  although the bias cannot  be fully  rem oved. Other confounders, such as
age,  sex,  region,  are  necessary  to  be  adjusted  for  in  the  analysis  too.  Energy
intake  m aybe  an  im portant  disease  predictor,  therefore  it  is  necessary  to  be
included in the regression model together with t he nut r ient  energy-adjusted term
(Willet t  1998) .
I n  the  UK Adults Brain  Tum our  Study  (UKABTS)  a  r ich  diet  dataset  is available  for
further  invest igat ions.
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1 .3 .3  Genet ic factors
Genet ics of brain tum our
Several studies were conducted invest igat ing whether genet ic changes or metabolic
suscept ibility  genes  have  a  role  in  brain  tum ours;  the  m ajor it y  of  the  evidence
supports the hypothesis that  genet ic changes can be assum ed to be a r isk factor
for  brain  tum ours  but  it  is  clear  that  m etabolic  suscept ibility  genes  play  lit t le,  if
any, role in brain cancer (Seym our, 2001) .
Brain  tum ours,  as  well  as  other  cancers,  result  from  a  mult iple  changes  in  cell’s
DNA  leading  to  tum our  form at ion  (Houben  2006) .  I t  is  believed  that  altered
(m utated)  or  m issing  genes enable  cancer  to  develop  (Jones et  al  2002) .  Som e of
these m utat ions are const itut ional and can be t ransm it ted from  one generat ion to
the next  (Houben 2006) .
The genes that  are involved in  the developm ent  of  brain  tum ours can  be classified
into three groups:  proto-oncogenes, tum our suppressor genes, and DNA repair
genes (Knudson AG. 2002) . The proto-oncogenes t ransform  into oncogenes with an
act ivat ing  mutat ion  in  one  or  both  gene  copies  and  st imulate  uncont rolled  cell
growth. An inact ivat ing m utat ion in both copies of the tum our suppressor genes
inhibit s  the  growth  of  cells  (Knudson  AG.  1971) .  Prevent ion  of  brain  tum our
form at ion  is  caused  by  DNA  repair  genes,  which  repair  DNA  dam age,  occur  by
m utagenic agents (Houben 2006) .
Candidates m utated or a ltered genes
Most  genet ic  invest igat ions  of  brain  tum ours  were  focused  on  m utat ion  and  gene
alterat ions ( loss of funct ion of tumour suppressor genes or overexpression of
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proto-oncogenes) . I t  is believed that  altered (mutated)  or m issing genes enable
cancer to develop (Jones et  al 2002) .  The loss of 17p ( including p53) , 9p, 10, 11p,
13q,  19  and 22q are some of  the alterat ions that  cause changes in  the expression
of several genes, such as phosphatase and tensin hom olog (PTEN) , deleted- in-
colon carcinom a (DCC) ,  epiderm al  growth  factor  receptor  (EGFR) , platelet -derived
growth factor receptor (PDGFR) ,  m ouse  double  m inute  2  (MDM2), glioma-
associated oncogene homolog (GLI ) , cyclic AMP-dependent  kinase number 2 A/ B
(CDKN2A/ B) , cyclin-dependent  kinase 4 and 6 (CDK4/ 6)  etc (Kleihues et  al 1999) .
Epidemiological studies that  conducted found that  altered genes involved in brain
tum ours, but  couldn’t  explain the role these genes play in brain tum ours form at ion.
The  m ost  com m on  altered  gene  that  seem s  to  involve  is  p53.  In  gliom as,  p53  is
the  m ost  frequent ly  altered  gene,  involved  in  the  early  phase  of  gliom a
developm ent  (Harada et  al  2003) .  According  to Bian  et  al  (2000) ,  the frequency  of
m utant  p53 protein expression was higher in grade 2-4 ast rocytom as than in grade
1  in  97  cases.  These  cases  were  invest igated  with  imm unohistochemist ry  and
im age  analyzer  to  detect  oncoproteins  and  it  was  concluded  that  p53  over-
expression  is  involved  in  ast rocytom as.  There  exist  data  (Khodarev  et  al  2004)
which  suggest  that  blockade  of  p53  funct ion  m ay  alter  the  relat ionship  between
tum our cells and endothelial cells,  such that  the latter  exhibit  an increase in radio-
sensit ivit y. According to Kut ler et  al (2003) , the squam ous cell carcinom as seen in
Fanconi  anaemia  pat ients  are  probably  caused  by  the  inact ivat ion  of  p53  by  HPV-
associated oncoprotein rather than by direct  m utagenesis.
Som e  other  altered  genes  which  have  an  involvem ent  in  carcinogenesis  of  brain
tumour are TP53 tumour suppressor gene, PTEN, CDK4, MDM2, CDKN2A tum our
suppressor gene and p14ARF. In the Kraus et  al (2002)  study, mutat ions of the
TP53 tum our suppressor gene were found in the 8%  of the supra-tentorial
pr imit ive neuroectodermal tum ours (sPNETs)  and in the 33%  of the glioblastom a
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m ult iform e  (GBM),  but  none  of  sPNETs  and  GBM  showed  allelic  losses  on
chrom osom e  arm  17p.  PTEN  m utat ions  were  detected  in  the  8%  of  sPNETs  and
17%  of GBMs but  none was carrying hom ozygous delet ion involv ing the CDKN2A
tum our  suppressor  gene.  The  CDK4  or  MDM2  proto-oncogenes  were  detected.
These result s indicate that  GBMs differ  from  sPNETs by  a higher  incidence of  allelic
losses  on  17p  and  TP53  mutat ions.  PTN  im munoreact iv it y  was  increased  in  low-
grade ast rocytom as com pared to normal brain (Ulbricht  et  al 2003) .  Although it  is
a  secreted  growth  factor,  it  appears  to  serve  as  a  subst rate  for  migrat ing  tum our
cells.  Another  study  is suggest ing that  in  cell cycle pathways,  deregulat ion of  G1-S
t ransit ion cont rol is one of the im portant  mechanisms in the development  of
ast rocyt ic gliom as through inact ivat ion of the p53 pathway. Abnormalit ies exist
either  by  m utat ion/ hom ozygous  delet ion  of  RB1  or  CDKN2A,  p16I NK4A  or
am plificat ion of CDK4 ( Ichimura et  al 2000) .
One exam ple of growth factor-regulated signalling pathways is that  of HI F-1, which
init iates the t ranscript ion of a num ber of genes, including those encoding vascular
endothelial  growth  factor  and  it s  receptors.  Also,  an  epiderm al  growth  factor
receptor  (EGFR)  gene is am plified or  mutated in 30-50%  of hum an glioblastom a
m ult iform e (Holland 2000) .  P53-m ediated apoptosis is involved in glioblastom as,
and  Apaf-1  is a  m ajor  effect .  The p53  gene mutat ion  and  EGFR gene am plif icat ion
were found in 13 cases (39% )  and 8 cases (24% ) , respect ively, and these gene
alterat ions were inversely correlated (Watanabe et  al 2003) .
 There are two proposed genet ic pathways that  link  clinical  findings with  m olecular
genet ic  evidence.  In  the  first  pathway,  it  is  believed  that  low  grade  ast rocytom as
can  be  developed  from  a  p53  m utat ion,  plus  PDGF  mutat ion,  PDGFR
overexpression  and  a  loss  of  gene  in  22p.  From  there,  a  ret inoblastom a  (Rb1)
alterat ion,  plus a loss of  genes on  19q and 9p  are responsible for  the form at ion  of
anaplast ic ast rocytom as and finally,  a loss of gene on 10q with an am plificat ion of
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PDGFR lead to a secondary glioblastom a (Lang et  al 1994, Louis et  al 1993) . In the
second hypothet ical pathway, it  is thought  that  EGFR and MDM2 amplif icat ion or
overexpression,  plus p16  delet ion,  loss of  genes on  10p  and  alterat ion  in  Rb1  and
PTEN can lead to a form at ion of prim ary glioblastom as (Watanabe et  al 1996) .
Even  though,  all  these mutated  or  altered  genes have been  suggested  to  have an
involvem ent  in brain tum ours, there is no clear  explanat ion why these healthy cells
t ransform  into  tum our  ones.  The  genet ic  aet iology  of  brain  tum ours  rem ains
puzzling and further invest igat ions need to be conducted in order to explain
whether gene alterat ions and mutat ions play a role in brain tum ours form at ion.
Hereditary factors
Only  about  5%  of  pr im ary  brain  tum ours  are  known  to  be  associated  with
hereditary factors (Bondy et  al 1991, Wrensch et  al 1997, Narod et  al 1991) . I n
part icular,  those  with  Li-Fraum eni  syndrome  (LFS)  (Li  et  al  1988) ,  tuberous
sclerosis  (Shepherd  et  al  1991) ,  neurofibromatosis  (Kinzler  et  al  1993) ,  Turcot
syndrom e  (Turcot  et  al  1959)  and  Gorlin  syndrom e  (Hahn  et  al  1996,  Corlin  et  al
1995) , have a higher incidence of brain tum ours than the general populat ion.
The heredit ary brain tum our syndrom es and the genes responsible for these
condit ions are sum m arised in the follow table ( table 3) .
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Table 1 . Hereditary bra in tum our syndrom es and corresponding tum our
types ( m odif ied from  Kleihues and Cavanee 2 0 0 0  and Current  Diagnosis &
Treatm ent  in Neurology book 2 0 0 6 )
Syndrom es Mutat ion Tum our type
Gardner syndrom e APC Colonic polyps,
ast rocytomas
Li-Fraum eni syndrom e P53 Mutat ion Solid systemic cancers,
ast rocytomas
,glioblastom as mult iform e
Mult iple endocrine
Neoplasia t ype
(MEN)  1
Chrom osom e 11 Pituitary adenomas
Neurofibrom atosis (NF)
types 1 and 2
Chrom osom e 17
NF1
Chrom osom e 22
NF2
Neurofibrom as, acoust ic
neurom as, m eningiom as,
ast rocytomas
Gor lin Chrom osom e 9
PTCH
Medulloblastom as,
ast rocytom as,
ependynom as,
glioblastom as mult iform e
Melanom a-astrocytom a CDKN2A Ast rocytom as,
m eningiom as, acoust ic
neuromas
Turcot  syndrom e Chrom osom e 5
APC
Colonic polyps,
ast rocytom as,
m edulloblastom as
Von-Hippel Lindau
syndrom e
Chrom osom e 3 I nfratentor ial and spinal
cord hemangioblastomas
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Genet ic polym orphism s and the r isk of brain tum our
Genes with mult iple alleles are called polym orphisms and seems to play a lit t le role
in brain tum ours development  (Seym our 2001) .  These genes are known to be
associated with different  processes such as oxidat ion, detoxif icat ion, DNA stability
and repair ,  and im mune funct ioning (Houben 2006) .
The best  studied polym orphism s are those in the carcinogen-m etabolising enzym es
glutathione  S-t ransferase  (GST) .  The  genes  encoding  GSTM1,  GSTT1,  and  GSTP1
are polymorphic (GSTM1 wildtype/null,  GSTT1 wildtype/null,  GSTP1 I le105V and
GSTP1 Ala114Val)  (Eaton et  al 1999) .  A stat ist ically  significant  associat ion between
GSTT1 null genotype and the risk of astrocytomas was reported in a previous study
(ast rocytom as:  OR 2.09, 95%  CI  1.28-3.39 and High Grade ast rocytom as:  OR
2.36, 95%  CI  1.41-3.94)  (Elexpuru-Camiruaga et  al,  1995) . Another case-cont rol
study found no associat ion between GSTT1 null and the risk of developing brain
tum our  (Trizna  et  al  1998) .  Evidence  exists  for  an  associat ion  between  GSTP1
I le105V genotype and glioma (OR 1.8, 95%  CI  1.2-2.7)  (De Roos et  al 2003) .
CYP  genes  are  also  involved  in  carcinogen  metabolism  and  detoxificat ion.  Even
though, no associat ion between CYP2D6 and gliom as is confirmed in a populat ion-
based case-control study (Kelsey et  al 1997) , a hospital-based case-cont rol study
showed  that  poor  m etabolising  variants  of  CYP2D6  were  associated  with  gliom as
(OR 4.17, 95%  CI  1.57-11.09)  (Elexpuru-Camiruaga et  al 1995) . Epidemiological
studies  were  not  reported  any  stat ist ically  significant  associat ion  between  CYP2E1
Rsa1 and Ins96 genotypes or  CYP1A1 Val/ Val genotype and gliom as (De Roos et  al
2003, Tr izna et  al 1998) .
Although, many polym orphisms have been studied their  involvem ent  in brain
tum ours  rem ains  unclear  and  cont roversial.  Several  problem s,  such  as  com bined
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analyses for histological subtypes, sm all sam ple size, insufficient  power, mistakes
in  the  study  design  or  inappropriate  stat ist ical  analysis  m ight  lead  to  wrong
associat ions (Houston et  al 2004, Bird et  al 2001) .
Genet ics sum m ary and suggestions for  the future
I n  previous  studies,  it  is  suggested  that  genet ic  changes  can  be  assum ed  to  be  a
r isk  factor  for  brain  tum ours.  I nvest igat ions  suggest  that  mutat ions  in  p53
(Watanabe et  al 2003, Harada et  al 2003, Bian et  al 2000, Khodarev et  al 2004,
Kut ler  et  al  2003) ,  PTENs  m utat ions  (Kraus  et  al  2002,  Ulbr icht  et  al  2003) ,
mutat ion/ hom ozygous delet ion of Rb1 or CDKN2A, p16I NK4A or amplif icat ion of
CDK4  ( I chim ura  et  al  2000,  Kraus  et  al  2002) ,  and  genet ic  polym orphism s
associated with basic cellular m etabolic processes such as oxidat ion, detoxificat ion,
DNA  stabilit y  and  repair ,  and  immune  funct ioning,  such  as  GSTP1  I 105V,  CYP2E1
RsaI  variants  and  GSTT1  null  genotype  (de  Roos  et  al  2003)  might  have  an
associat ion with a raised occurrence of  cent ral nervous system  (CNS)  tum ours.
Also, 5%  of brain tum ours are known to have associat ion with hereditary
syndrom es, such as Li-Fraum eni, tuberous sclerosis, neurofibrom atosis, and Turcot
syndrom e (Wrensch  et  al  1997,  Malkin  et  al  1990,  Shepherd  et  al  1991,  Kinzler  et
al 1993, Todd et  al 1981) .
Despite  of  the  effort s  of  m any  invest igators  in  the  genet ic  area  of  research,  the
lim ited  available  findings failed  to  indent ify  m ajor  genet ic factors for  the  aet iology
of brain tum ours (Houben 2006) .  Further studies need to be conducted, taking into
account  som e m ethodological considerat ions and new approaches of analysis.
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Methodological considerat ions
The  first  thing  that  is  necessary  to  consider  is  the  classificat ion  of  brain  tum ours.
Brain  tum our  studies  have  som e  problems  as  there  is  often  a  histologically
difference between the brain tum ours examined.  Today,  we are using the standard
classificat ion  list  of  the  World  Health  organisat ion  (WHO),  which  is  based  on  the
knowledge we have by now of the histopathology and genet ics of brain tum ours
(Kleihues et  al 2000) .  The heterogeneit y in morphology and m alignancy grade of
brain tum ours,  the diff icult ies to m ake an accurate diagnosis of  the specific t ype of
brain  tum ours,  the  sm all  num ber  of  histopathological  cr it eria  to  observe  a
classificat ion, in addit ion with the fact  that  som e brain tum ours show
characterist ics that  fit  more than one type can lead to misclassificat ions (Kleihues
et  al 2000) .
Another  potent ial problem  that  occurs in genet ic epidemiological studies is the
genet ic heterogeneit y  of  brain  tum ours (Houben  2006) .  Mutat ions or  alterat ions in
different  genes  can  have  an  involvement  in  the  sam e  phenotype  of  brain  tum our.
Also, it  is possible these different  mutat ions to be responsible for  the developm ent
of  a  specific  t ype  of  m alignancy,  but  afterwards  to  follow  a  com pletely  different
genet ic pathway (Kleihues et  al 2000, Ohgaki et  al 2005) .
The difficulty to obtain substant ial group of pat ients for the studies is another
major problem that  genet ic epidem iology faces. The low worldwide incidence of
brain tum ours (3.7 per 100 000 persons-years in males and 2.6 per 100 000
persons-years  in  fem ales)  (CBTRUS  Stat ist ical  Report  2007-2008) ,  and  the  high
m ortalit y  rate  of  the  disease  (5.0  per  100  000  persons-  years  in  Great  Britain)
(Office of Nat ional Stat ist ics,  Mortality  Stat ist ics,  England and Wales 2007,
accessed February 2009)  m ake the situat ion very difficult ,  as there is not  enough
t im e to invit e part icipants (cases)  and collect  the genet ic m aterial (blood sam ples) .
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Therefore, specif ic large-scale mult icent re projects m ust  be designed with
internat ional collaborat ions in order  to achieve sufficient  sam ple of cases and be
able  to  support  the  hypotheses  (Wrensch  et  al  1997,  Krishnan  et  al  2003,
Kleinerm an et  al 2005, I nskip et  al 2001) .
Suggest ions for future research
I n the last  years we face an evolut ion of genet ic epidem iological m ethods. The
com plete  nucleot ide  sequence  of  the  hum an  DNA is  available  (Venter  et  al  2001) ,
an  int roduct ion  to  DNA  m icroarrays  for  quick  genotyping  was  m ade
Sachidanandam  et  al 2001)  and SNP markers and polym orphic m icrosatellit e
m arkers can  be use achieving  high  rates of  genotyping  success (Evans et  al  2004,
Sawcer  et  al  2004) .  All  these increase the am ount  of  inform at ion  for  genet ics and
invest igators need to focus on the data m anagem ent  and analysis of these outputs.
Aet iological hypotheses need to form ulate regarding consistent ly  observat ions of
brain tum our epidem iology. Therefore, sex differences, age, geographical
var iat ions, ethnicit y ,  deprivat ion category and lifestyle worth to take into account
(Preston-Mart in et  al 1996) .
I n addit ion, a new approach of studying gene-environm ental interact ion should be
considered with  at tent ion,  as it  m ight  be the direct ion  of  the future (Brennan  et  al
2002) .  This  approach  should  com bine  relevant  genet ic  polym orphism s  and
environm ental exposure. As we have m ent ioned above, in the “dietary factors”  part
of the chapter,  there are som e nut rient  com pounds (e.g. ant ioxidants)  which can
modulate the effects of potent ial carcinogens. Also, exposure to carcinogenic
chem icals might  have effects on suscept ible genes polym orphism s, which are
associated  with  carcinogen  m etabolising  enzym es  or  DNA  repair  capacity.  These
invest igat ions could explain the role that  both genet ic and environm ental
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exposures play in brain tum ours. These studies require a large dataset ,  which is
difficult  to obtain due to the methodological considerat ions we have ment ioned
above.
A  new  sub-group  analysis  approach  m ay  be  the  key  to  unravelling  the  role  of
m etabolic genes in cancer suscept ibilit y. According to the art icle by Seym our Garte
(2001) ,  “when  part icular  groups of  case populat ions are  examined  separately,  the
im portance of these genet ic polymorphisms may often becom e quit e clear” . This
view is supported with examples (Seym our Garte, 2001)  and, even though m any
ethical,  legal,  sociological and scient if ic issues are raised, there is opt im ism  that
epidem iological studies of well- defined sub-groups rather  than whole populat ion
m ay be the best  path of cancer invest igat ion.
1 .3 .4  Other r isk  factors
Radio Frequency Exposures
Many reports cont inue to be published suggest ing that  there might  be health r isks
from  exposure  to  radio  frequency  electrom agnet ic  radiat ion,  but  the  balance  of
evidence  does  not  suggest  RF  is  carcinogenic  (NRPB  1993,  Stewart  2000) .
Telecom municat ions  devices  and  m obile  phones  suggested  being  a  cause  of  brain
tumours. Epidem iological studies of Telephone Company billing records in the USA
(Funch  et  al  1996,  Rothm an  et  al  1996a,  Rothm an  et  al  1996b)  did  not  find  that
using billing records was a good measure of exposure to cellular phones and no
significant  increased  m ortality  was  observed  in  m obile  phone  users  com pared  to
the general populat ion.  Three recent ly published case cont rol studies of brain
tum ours and m obile phone use, including two large studies in the US, one with 782
cases  and  779  cont rols  ( Inskip  et  al  2001)  and  the  other  one  with  469  cases  and
422 cont rols (Muscat  et  al 2000)  and a com parat ively  sm all one from  Sweden (233
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cases/ 466 cont rols)  (Hardell et  al 1999) ,  failed to find ident ify  any overall
increased r isk for brain tum ours. A further com prehensive cohort  study of m obile
users from  Denm ark  found no increased r isk  of  brain  or  any  other  cancer  linked to
pat terns of use (Johansen et  al 2001) .
Occupat ional Chemical Exposures-Pest icides
Exist ing data from  epidemiological studies support  the hypothesis that  occupat ional
exposure  to  chemicals  has  an  associat ion  with  brain  tum ours.  A  review  of  11
studies  of  the  pet rochem ical  indust ry  (Alderson  1986)  gave  a  com bined
observed/ expected (O/ E)  of  1.16.   Studies have dem onst rated a range of  jobs with
elevated  risks of  brain  tum ours,  which  m ay  involve solvent  exposure (Thom as and
Waxweiler  1986) .   A  risk  for  vinyl  chloride  workers  has  not  been  substant iated
(Alderson 1986, Burch et  al 1987)  and equivocal results are present  for risks linked
to the rubber indust ry (Thom as and Waxweiler  1986, Preston-Mart in et  al 1989,
Burch  et  al  1987) .   Increased  m ortalit y  from  brain  tum ours  has  been  observed  in
chem ists and  laboratory  workers in  different  count ries (Alderson  1986,  Rut ty  et  al
1991,  Carpenter  et  al  1991)  and  som e  (Harr ington  and  Oakes  1984,  Hall  et  al
1991)  but  not  all  studies  (Carpenter  et  al  1997)  of  pathologists.   No  specific
common exposure has been ident ified.
Also, epidem iological studies indicate that  occupat ional exposure to pest icides m ay
play  a  role  in  the  development  of  brain  tumours.  Pest icide  exposure  and  links
between brain tum ours and agricultural occupat ions, part icularly farmers, and
agricultural research have emerged from several invest igat ions (McLaughlin et  al
1987, Musicco et  al 1982, Ahlbom  et  al 1986, Morr ison et  al 1992, Firth et  al 1996,
Daly  et  al  1994,  Jim my  T.  Elfird  2003) .   Current  inform at ion  on  pest icide exposure
fails  to  provide  clear  evidence  of  a  r isk  for  brain  tum ours  (Bohnen  and  Kurland
1995) .  According  to Ana Navas –Acien  et  al  2002  the effect  of  pet roleum  products
was independent  of the intensit y of ELFMF exposure whereas solvents, lead, and
pest icides were only associated with gliom a in workers.
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Radiat ion
The  Biological  Effects  of  I onizing  Radiat ion,  BEI R  V report  (1990)  ident if ied the
brain  as  a  radiosensit ive  organ  at  risk  of  malignancy  following  high  doses  of
ionising  radiat ion  in  utero.   Exposure  to  dental  x- rays appears to  increase the risk
of  developing  a  brain  tum our  in  som e  studies  (Neuberger  et  al  1991) ,  but  not  in
others (Schlehofer  et  al 1992,  Ryan et  al 1992)  and therapeut ic CNS radiat ion m ay
increase the r isk  of  developing  a  prim ary  cerebral  tum our  (Hodges et  al  1992) .   A
15 per cent  excess m ortalit y from  brain tum ours was observed in a large cohort
study  of  Am erican  nuclear  workers  (1.6  m illion  person  years  of  observat ion)
suggest ing a risk for exposure to accum ulated low doses (Alexander 1991) .
Head Traum a
I ndividual studies have dem onst rated a relat ionship between serious head injury
and meningiom as (not  gliom as)  (Preston-Mart in et  al 1989)  and int racranial
vascular  tum ours  ( Inskip  et  al  1998) .  A  Catharina  Nygren  et  al  2001  study  found
no associat ion between t raum at ic brain injury and brain tum ours. Ser ious t raum a
to the head should be accounted for  in future invest igat ions.
Viruses
Animal models have provided lim ited support  t o the hypothesis that  viruses may be
involved  in  the  aet iology  of  brain  tum ours  (Schoenberg  1982) .   I n  general,
epidem iological studies have been inadequate to clarify  this,  although a recent
study in the US showed no evidence of a link between polio vaccine contam inated
with SV 40 and brain tum ours (Str ickler et  al 1998) .   Two laboratory invest igat ions
have found integrated SV 40 viral sequences in tum our t issue of ependym om as
and  choroids  plexus  papillom as (Bergsagel  et  al  1992,  Lednicky  et  al  1995) .   This
rem ains an issue of interest .
41
1 .4 . AI MS
The aim  of this study is to invest igate the link between cumulat ive elect rom agnet ic
field  (EMF)  exposure,  which  reflected  lifet im e  exposure,  rather  than
elect rom agnet ic  field  (EMF)  exposure  from  any  specific  job  and  gliom a,
m eningiom a and acoust ic neurom a.
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2 . Design and Methods
This  chapter  describes  the  background  of  the  UK  Adult s  Brain  Tum our  Study
(UKABTS) .  Based  on  the  protocol  and  previous  studies  of  the  UK  Adults  Brain
Tum our  Study  (UKABTS)  (Hepworth et  al 2006a,  Hepworth et  al 2006b) ,  we report
the  procedure  for  the  select ion  of  cases  and  cont rols.  This  chapter  is  followed  by
inform at ion  for  the  occupat ional  and  diet  data  collect ion.  Finally,  m ethods  for
calculat ing  the  exposure  to  elect rom agnet ic  fields  are  explained,  as  well  as  the
analysis plan we followed to invest igate the associat ion of elect rom agnetic f ields
(EMF)  with brain tum ours.
2 .1  Ethics Approval
The study has been approved by the Mult i-Cent re Research Ethics Comm ittee
(MREC)  for  Scot land  ( reference  MREC/ 99/ 0/ 77) .   All  relevant  Local  Medical
Research Ethics Comm it tees and hospit al t rust  ethics com mit tees in the study
areas have been approached and given their approval.
2 .2  Study background and design
I n  2001,  the UK Adult  Brain Tum our  Study  (UKABTS)  began to invest igate the role
of  a num ber  of  environm ental agents in  the onset  of  brain cancer.  The study  is the
collaborat ion between three inst itutes including the Departm ent  of Epidem iology
and Public Health of University of Not t ingham, the Cent re for  Occupat ional and
Environm ental Health of Universit y of Manchester and the Unit  of Epidemiology and
Health  Services  Research  of  Leeds  Universit y.  The  UKABTS  is  part  of  an
internat ional case-cont rol study of adult  brain tum ours ( the I NTERPHONE study) ,
co-ordinated  at  the  Internat ional  Agency  for  Research  on  Cancer  ( I ARC) .   The
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I NTERPHONE was set  up  to  invest igate  the  associat ion  between  m obile  phone use
and incidence of brain cancers (Cardis and Kilkenny, 1999) .
The  UKABTS  is  a  case-cont rol  study.   The  study  was  conducted  in  four  cent res:
cent ral  Scot land,  Trent ,  West  Midlands  and  West  Yorkshire  (Hepworth  et  al.,
2006a;  Hepworth  et  al.,  2006b) .   All  cases  and  cont rols  were  interviewed  by
t rained  interviewers,  using  a  com puter  assisted  personal  interview   (CAPI )  system
(Hepworth  et  al.,  2006b) .   I n  addit ion  to  dem ographics,  health  inform at ion  and
inform at ion  on  the use of  m obile phones,  data were also collected  on  occupat ional
sources of electrom agnetic fields and diet .   A full occupat ional history of all jobs
held longer than 12 m onths from  leaving school to the present  day was obtained
by self administered quest ionnaire, sent  t o respondents prior to the interview.
Data  for  EMF exposure  required  Job  t it le,  indust ry,  date  of  start ing  and  finishing
each  job.  After  a  face to  face interview  each  part icipant  was left  a  food  frequency
quest ionnaire (FFQ)  on dietary intake to com plete and return by post  to the study
cent re.  Part icipants  were  asked  to  recall  their  diet  in  the  past  two  years.  Blood
sam ples are taken from  m ore than 90%  of cases and cont rols, and serum  and DNA
stored to invest igate genet ic predisposit ion and v iral status.
Eligible  cases  were  aged  18-69  years  and  resident  in  the  study  areas,  first
diagnosed between 1st Decem ber  2000  and  30 th June  2003,  with  gliom a  ( I CDO-3
topography: C71, m orphology:  9380-9411,9420-9451,9480,9505) , meningioma
(topography:  C70.0, morphology:  9530-9539)  or acoust ic neurom a ( topography:
C72.4, m orphology:  9560/ 0)  (World Health organizat ion, 2000) .
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2 .3 .1  Select ion of cases
I ncident  cases  from  a  defined  geographical  area  were  defined  according  to  the
following crit er ia:
1) Diagnosis:
a) a histologically  confirmed prim ary int racranial tum our
b) tum ours diagnosed by scans and radio im aging
c) localisat ion of tumours
2) Age:  Between  18  and  69  years  old  at  the  t ime  of  diagnosis,  to  allow  a
reasonable period of occupat ional exposure.
3) Geographical area:  Living in one of the 4 study areas (Cent ral Scot land,
West  Yorkshire,  Trent ,  West  Midlands) .
Mult iple  sources  were  used  for  case  finding  through  act ive  m echanism s  and  seek
collaborat ion with t reat ing cent res.  Case ascertainm ent  was proact ive and rapid,
aiming to have not if icat ions within 3 weeks of diagnosis.   A feasibility  study had
established the m echanism  of collaborat ion and the enthusiast ic support  of
clinicians.  Neurosurgeons, neurologists, neuro- radiologists, neuro-oncologists,
neuro-pathologists and Cancer Regist ries were all to provide not ificat ions and the
required informat ion.  Many centres had mult idisciplinary team s involved in
t reatm ent  that  facilit ated case ascertainm ent  and local arrangem ents had been
m ade  to  take  account  of  the  wishes  of  the  clinical  collaborators  and  their  staff.
System at ic crosschecks with the cancer regist r ies opt im ised ascertainm ent  and
ensured that  the proport ion of interviewed cases in the population could be
calculated.
Eligible  cases  were  approached  through  their  t reat ing  consultants.   Surrogate
interviews were undertaken as an alternat ive for  those with condit ions which m ade
interview im possible or for  those who had died.
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2 .3 .2  Select ion of controls
Cont rols were populat ion-based and the eligibilit y  crit er ia for  the cont rols were set
as follows:
Cont rol ascertainm ent  -  procedures  for  select ion  varied  slight ly  by  region  but  all
achieved the following:
‚ Random  select ion  of  a  set  of  eligible  controls  from  an  ent ire  GP  pract ice  list
either where the case was registered or a pract ice nearby.
‚ Each  cont rol  was  m atched  with  one  case  of  the  sam e  age  or  up  to  one  year
older and of the sam e sex.
Approach  to  cont rols  was  also  done  through  their  GP  and  by  let ter  and  their
part icipat ion in the study was ent irely voluntary.
2 .3 .3  Occupat ional Data
The occupat ional data were obtained by  a self  adm inistered quest ionnaire that  was
sent  to  respondents  pr ior  to  the  interview.  They  were  asked  to  give  a  full
occupat ional  history  of  all  jobs held  longer  than  12  m onths from  leaving  school  to
the  present  day.   Part icipants  were  asked  to  com plete  an  occupat ional  calendar
where job  t it le,  indust ry,  date  of  start ing  and  finishing  each  job  were required.  All
occupat ional  calendars  were  collected  from  the  t rained  interviewers  at  the  end  of
each face to face interview.
Coding of Occupat ional Histor ies
All  occupat ions in  the  occupat ional  calendar  were  coded  by  the study  interviewers
according  to  the  Standard  Industr ial  Classificat ion  (SI C)  (The  Office  for  Nat ional
Stat ist ics, 1992)  and the Standard Occupat ional Classificat ion (SOC)  (The Office for
Nat ional Stat ist ics, 2000) .  The com plet ion of SIC and SOC codes was checked.
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2 .3 .3 .1  Scoring occupat ional exposure to electrom agnet ic fields
I n  this  study,  using  the  secondary  occupat ional  data,  m y  role  was  to  score  the
exposure to elect rom agnet ic fields and then to conduct  a stat ist ical analysis to see
whether occupat ional exposure to EMF is a potent ial r isk factor for  brain tum ours.
First  of  all,  an  appropriate geom et r ic m ean  (GM)  of  electrom agnet ic field  exposure
had to be given for  each Standard I ndust rial Classif icat ion (SI C)  and each Standard
Occupat ional  Classificat ion  (SOC)  code.  My  involvem ent  was to  link  these SI C and
SOC codes with the appropriate geom et ric mean of the exposure.
Each Standard Indust r ial Classif icat ion (SI C)  and each Standard Occupat ional
Classificat ion (SOC)  code was allocated electrom agnet ic fields (EMF)  Geom etr ic
m ean  from  a  previous  analysis  that  searched  for  determ inants  of  occupat ional
exposure to ext rem ely low frequency elect rom agnet ic f ields in the general
populat ion  in  the  UK  (Van  Tongeren  et  al.,  2007) .   There  were  1240  of  9992  job
subjects  whose  SOC  codes  could  not  be  m atched  with  the  exist ing  list  of
elect rom agnet ic fields (EMF)  geometr ic m eans. These SOC codes were linked with
the UKSoc2000 list  (SOC code list  2000)  and the US80 list  (SOC code list )  in  order
to  classify  them  in  an  occupat ional  category  that  a  geom et ric  m ean  of
elect rom agnet ic field exposure exists.  Since the two lists were to som e extent
different ,  the I SCO88  (a list  m atching  the soc codes for  USA and UK) ,  was applied
to  aid  the  coding  procedure.  Ult im ately,  som e  SOC codes  were  st ill  unable  to  be
m atched,  so the geom et ric mean  of  exposure for  these codes reported  as missing.
This procedure helped to reduce the num ber of subjects with m issing EMF data and
opt im ized  the  use  of  available  data.   This  procedure  cannot  be  applied  with  SI C
codes as there is no specific list  linking the UK SI C codes and the US SI C codes.
According to the Standard Indust r ial Classif icat ion (SI C) , the minor group with the
highest  geom et ric  m ean  of  exposure  to  elect rom agnet ic  fields  is  the  “elect ricity
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generat ion  and  supply”  (SI C:  40,  geom et ric  mean:  1.58) ,  followed  by  the  minor
group of  “publishing,  print ing,  reproduct ion”  (SIC:  22,  geom et ric m ean:  0.27) .  The
m inor  groups of  “hotels and restaurants”  (SI C:  55)  and “m anufacture of  basic and
fabricated  m etals”  (SI C:  27-28)  have also  a  high  geom et ric m eans,  GM:  0.20  and
GM:  0.18 respect ively.
 For  the Standard  Occupat ional  Classificat ion  (SOC)  the minor  group of  “m anagers
in  hospitality  and  service  indust ry”  (SOC:  122,  123)  has  the  highest  geom et ric
m ean of  exposure (GM:  0.19) ,  followed by  the m inor  group of  “other  m anufacture”
(SOC:  541, 524, 549, 8111, 8116)  with geom et ric mean 0.19. The groups of
“metal and vehicle workers”  (SOC:  521-523, 8117, 812, 813)  and “administ rat ive
jobs”  (SOC:  1,  42)  have geomet ric m ean of  exposure 0.13.  The group of  “elect rical
t rades”  (SOC:  524)  has also a high  geom et r ic m ean  of  exposure (GM:  0.12) .  Also,
“construct ion”  (SOC:  531,  814)  and  “packers,  warehouse”  (SOC:  13,  914)  groups
have geom etr ic m ean of exposure to elect rom agnet ic fields 0.10.
The Standard Occupat ional Classif icat ion (SOC)  list  focuses on the job t it le and the
descript ion  of  the  work  each  person  is  doing  in  order  to  classify  the  occupat ion
groups. On the other hand, Standard Indust rial Classificat ion (SI C)  codes indicate
the com pany’s t ype of business. Therefore, each group might  have different
occupat ions  and  this  can  be  an  explanat ion  for  possible  differences  between
geom et ric  m eans  of  exposure  to  electrom agnet ic  fields  of  sim ilar  groups  by  SI C
and  SOC codes.  For  exam ple  the  “elect ricity  generat ion  and  supply”  group  of  SI C
list  has  geom et ric  m ean  1.58,  but  the  group  of  “elect r ic  t rades”  of  SOC  list  has
geom et ric m ean 0.12. Despite this, the geom et ric m eans of exposure of sim ilar SI C
and SOC groups do not  have much difference, especially  for  groups with low
exposure to electrom agnet ic fields.
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The cum ulat ive exposure to EMF for each part icipant , was calculated using the
m athem at ical formula
daysmonthstotaljobtitleeachfornmeageometric
n
i
28612
1
·„·Â
?
where n=  the num ber of j obs each part icipant  has held.
The total working days for Br it ish people is 286 days from  365 (365 [ total days in 1
year]  –  56 [ Saturday  and Sunday  for  all 12 m onths]  -8  [ official bank  holidays]  -15
[ the  ent it lem ent  for  3  weeks  holiday  including  5  working  days  per  week  with
Saturdays and Sundays not  included as they were already excluded from  the total
of  12  m onths] ) .   No  off  sick  days  were  accounted  for.   The  geom et r ic  m ean  for
elect rom agnet ic field  exposure for  each  job  was based on  the SI C and SOC codes.
With this form ula, each part icipant  has a cumulat ive exposure to EMF depending on
the jobs he/ she had had up to the data collect ion date.
2 .3 .3 .2  Stat ist ica l analysis
An epidemiological (case-cont rol)  analysis was conducted to establish occupational
exposure to elect rom agnet ic fields effect  on brain tum ours. This analysis carried
out  in  SPSS  and  provided  OR  est im ates  95%  confidence  intervals  (CI )  and
significance levels.
Descr ipt ive stat ist ical m odels were used to check for frequencies and to summ arise
the  baseline  character ist ics  of  the  study  populat ion.  Histogram s did  not  support  a
norm al  dist r ibut ion  of  electrom agnet ic  field  (EMF)  data  and  a  non  paramet ric  test
was em ployed to check the differences in rankings of elect rom agnet ic fields
exposure.
To  assess  est im ated  risks,  the  total  EMF  for  both  SI C  and  SOC  codes  for  all
subjects  was  categorised  into  quart iles,  based  on  cont rol  group  quart ile
distr ibut ion.  Collect ively,  an uncondit ional logist ic regression adjusted for  age (5
year  age groups) ,  sex,  region (n= 4) ,  and deprivat ion category  based on Townsend
score (n= 5)  (Townsend,  1987)  was carried out .    Analyses were also carried out  to
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assess  the  r isk  for  each  type  of  brain  tum our  including  gliom a,  m eningiom a  and
acoust ic neuroma.
2 .4  Pow er of the study –  all outcom es included
I n case-cont rol studies, it  is not  possible to direct ly est im ate disease incidence in
those  exposed  and  those  unexposed,  since  people  are  selected  on  the  basis  of
having  or  not  having  the  condit ion  of  interest ,  not  on  the  basis  of  their  exposure
status.  I t  is,  however,  possible  to  calculate  the  odds of  exposure  in  the  cases and
in the controls.  The power  of  a case-cont rol study  is defined as the probabilit y  that
a signif icant  difference will be found between the case and control groups, given
that  a t rue difference exists.
As we have m ent ioned in the previous section, lim ited data exist  regarding
associat ion between occupat ional exposure to elect romagnet ic fields and brain
tum ours. All previous studies were looking at  specific rather than lifet im e exposure
to elect rom agnet ic fields;  therefore there is no evidence of how big is the effect  of
lifet im e occupat ional exposure to elect rom agnet ic fields to the r isk of having brain
tum our. Considering that  odds rat ios are higher when we study the associat ion
between  exposure to elect rom agnet ic fields for  specific occupat ions and the risk  of
brain tum our,  instead of lifet ime exposure to elect rom agnetic fields,  we select  an
odd rat io of 1.5 for the effect  est im ate we intended to detect  in our study.
The total num ber of 2067 subjects (970 cases and 1097 cont rols)  that  included in
the stat ist ical  analysis allows us to  have 95%  power  of  detect ing  a  relat ive  r isk  of
1.5,  at  5%  level  of  significance.  Therefore,  for  the  ent ire  group  of  all  brain
tum ours,  the  study  has  sufficient  power.  There  are  588  gliom as  included  in  the
analysis comprising approxim ately the 60%  of all cases. Even for this restr icted
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group  we can  est im ate  sufficient  power  of  95%  of  detect ing  a  relat ive  r isk  of  1.5,
at  5%  level  of  significance.  Sm aller  sub-groups of  tum ours (247  m eningiom as and
135  acoust ic  neurom as)  will  have  reduced  power  (approxim ately  86%  for
m eningiom as and approxim ately 77%  for acoust ic neurom as)  to detect  risks as low
as 1.5, at  5%  level of significance.
52
53
3 . Results of elect romagnet ic fie lds exposure and the r isk of brain tumours
This chapter presents the results from  the stat ist ical analysis that  was conducted to
find associat ion between elect rom agnet ic fields exposure and brain tum ours.
Dem ographic  inform at ion  as  well  as  part icipat ion  and  refusal  num bers  is
dem onst rated. Mean and m edian values for cum ulat ive elect rom agnet ic fields
exposure have been com pared between cases and cont rols.  Finally ,  the distr ibut ion
of subjects by Standard I ndust r ial Classificat ion (SI C)  and Standard Occupat ional
Classificat ion (SOC)  codes based on quart iles distr ibut ion and the est im ated r isks
for  the  occupat ional  and  industr ial  exposure  to  elect rom agnet ic  fields  (EMF)  is
presented.
Part icipat ion and dem ographic inform at ion for overa ll populat ion
I n the UK Adults Brain Tum our Study (UKABTS)  1408 cases and 2491 controls
were selected. From  the 1408 cases the 946 were gliom as, the 310 m eningiom as
and  the  152  acoust ic  neurom as.  Finally,  the  part icipants  in  the  study  were  978
cases and  1100  cont rols.  The response rate  was approxim ately  70%  am ong  cases
and 44%  among cont rols. The m ain reasons for not  taking part  for cont rols was
non- response (26% )  or refusal (22% ), whilst  for the cases the m ain reasons for
non- response  were  death/ too  ill  (19% )  and  refusal  (11% ) .  The  following  table
(Table  3.1)  summ arises  the  inform at ion  on  part icipat ion  and  refusal  in  the  UK
Adults Brain Tum our Study.
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TABLE 3 .1   Pa rt icipat ion and refusal info in the UK Adults Brain Tum our Study ( UKABTS)
Cases
  n( % )
Gliom a
n ( % )
Meningiom a
n ( % )
Acoust ic
Neurom a
n ( % )
Cont rol
n ( % )
All e lig ible
part icipants
978(70) 593 (63) 250 (81) 135(89) 1100(44)
Part icipants
w ith e xposure
  inform at ion
499(35) 247 (26) 167 (54) 85 (56) 1033(41)
 N on-
part icipants
Consultant / GP 29(2) 26 (3) 3 (1) 0 (0) 179(7)
Deceased/ too ill 197(14)     183(19) 14 (5) 0 (0) 4(< 1)
N on- response 32(2)        22 (2) 8 (3) 2 (1) 658(26)
Refusal 149(11)    103(11)    32(10) 14 (9) 538(22)
Other 17(1)         13 (2) 3 (1) 1 (1)    9 (< 1)
No
occupa t ional
calendar
6(< 1)     6 (< 1) 0 (0) 0 (0)    3 (< 1)
        Tota l    1408(100)     946(100) 310(100) 152(100) 2491(100)
I n this study a total num ber of 2067 subjects (970 cases and 1097 cont rols)  were
included in the stat ist ical analysis (gliom as n= 588;  meningiom as n= 247;  acoust ic
neurom as  n= 135;  cont rols= 1097) .  That  shows  that  there  was  a  loss  of  only  8
cases and 3 cont rols of the part icipants in the m ain UK Adults Brain Tum our Study
(UKABTS) .  This is a  very  sm all  num ber  of  subjects without  occupat ional  calendar;
represent  less than  1%  of  all  part icipants.  Due to this fact  our  results have no lost
of power.
Table 3.2 provides dem ographic informat ion on the part icipants. Approximately,
62%  of  gliom as  cases  were  m ale,  whilst  for  the  m eningiom as  and  acoust ic
neurom as  the  m ajor it y  was  fem ale  (74.1%  and  57.0%  respect ively) .  There  was
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approxim ately  equal  proport ion  of  m ales  and  fem ales  (50% )  am ong  all  cases,  as
well  as am ong the controls.  I ndependent  age dist ribut ion  for  all  cases and cont rols
was not  diverged,  as for  each 5-years age group approxim ately  equal proport ion of
cases and cont rols were seen. Most  of the cases and cont rols were ranged between
the  ages  of  50  to  64.  Approxim ately  the  sam e  age  dist r ibut ion  was  seen  for  the
subgroup  of  gliom as com pared  to  cont rols.  At  the  age  range  of  45  to  64  a  higher
proport ion was seen for  m eningiomas (age 45-49:  13.8% , age 50-54:  19% , age
55-59:  17.4% , age 60-64:  17.8% , age 65-69:  6.9% )  com pared to controls (age
45-49:  12.2% , age 50-54:  17.5% , age 55-59:  16.8% , age 60-64:  15.5% , age 65-
69:  5.7% ). For acoust ic neurom as a higher proport ion com pared to cont rols was
seen  at  the  age range of  35  to  49  (age 35-39:  acoust ic neurom as 13.3% -cont rols
9.1% , age 40-44:  acoust ic neurom as 14.8% -cont rols 10.5% , age 45-49:  acoust ic
neurom as 13.3% -controls 12.2% ) . A higher proport ion of both cases and controls
were seen in the m ost  affluent  Townsend score com pared to the other points of
Townsend  score  (all  cases  26.9  % ;  gliom as  28.4  % ;  m eningiom as  24.7  % ;
acoust ic neurom as 24.4%  and cont rols 29.8% ). A higher proport ion of cont rols
were classified in the m ost  affluent  Townsend score com pared to cases, especially
when com pared to m eningiom as and acoust ic neurom as cases. A higher proport ion
of  both cases and cont rols were seen for  region of  Trent  (all cases 34.4% ;  gliom as
33.7% ;  m eningiom as 38.5% ;  acoust ic neurom as 30.4%  and cont rols 33.9% ) .  The
region  of  West  Midlands  has  the  less  proport ion  of  all  cases  (17.5% ) ,  gliom as
(18.9% ) ,  meningiom as  (10.5% )  and  cont rols  (18.6% ) ,  and  only  for  acoust ic
neurom as the less proport ion were seen for the region of West  Yorkshire (16.3% ) .
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Table 3 .2 . Dem ographic inform at ion for all study part icipants
All cases
( n= 9 7 0)
Gliom a
( n= 5 8 8)
Meningiom a
( n= 2 4 7)
Acoust ic
Neurom a
( n= 1 3 5)
Control
( n= 1 0 97 )
All n ( % ) All n ( % ) All n ( % ) All n ( % ) All n ( % )
Sex
Male
Fem ale
487 (50.2)
483 (49.8)
365 (62.1)
223 (37.9)
 64  (25.9)
 183 (74.1)
 58 (43.0)
 77 (57.0)
 543 (49.5)
 554 (50.5)
Age (5 years group)
18-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
59 (6.1)
61 (6.3)
88 (9.1)
103 (10.6)
117 (12.1)
171 (17.6)
167 (17.2)
149 (15.4)
55 (5.7)
43  (7.3)
42  (7.1)
53  (9.0)
55  (9.4)
65  (11.1)
104 (17.7)
105 (17.9)
85  (14.5)
36  (6.1)
 7   (2.8)
 10  (4.0)
 17  (6.9)
 28  (11.3)
 34  (13.8)
 47  (19.0)
 43  (17.4)
 44  (17.8)
 17  (6.9)
 9   (6.7)
 9   (6.7)
 18  (13.3)
 20  (14.8)
 18  (13.3)
 20  (14.8)
 19  (14.1)
 20  (14.8)
 2    (1.5)
 70  (6.4)
 70  (6.4)
 100 (9.1)
 115 (10.5)
 134 (12.2)
 192 (17.5)
 184 (16.8)
 170 (15.5)
 62  (5.7)
Region
1 Scot land
2 West  Yorkshire
3 West  Midlands
4 Trent
255 (26.3)
211 (21.8)
170 (17.5)
334 (34.4)
150 (25.5)
129 (21.9)
111 (18.9)
198 (33.7)
66 (26.7)
 60 (24.3)
 26 (10.5)
 95 (38.5)
 39 (28.9)
 22 (16.3)
 33 (24.4)
 41 (30.4)
 280 (25.5)
 241 (22.0)
 204 (18.6)
 372 (33.9)
Deprivat ion score
1 (m ost  affluent )
2
3
4
5 ( least  affluent)
261 (26.9)
227 (23.4)
166 (17.1)
184 (19.0)
132 (13.6)
167 (28,4)
136 (23.1)
99  (16.8)
108 (18.4)
78  (13.3)
 61 (24.7)
 62 (25.1)
 40 (16.2)
 45 (18.2)
 39 (15.8)
 33 (24.4)
 29 (21.5)
 27 (20.0)
 31 (23.0)
 15 (11.1)
 327 (29.8)
 247 (22.5)
 199 (18.1)
 183 (16.7)
 141 (12.9)
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Cum ulat ive electrom agnet ic field exposure
Figures  3.1  are  histogram s  of  the  dist r ibut ion  of  total  electrom agnet ic  field
exposure by Standard Indust r ial Classificat ion (SIC)  and Standard Occupat ional
Classificat ion (SOC)  between cases-cont rols and diagnosis groups (gliom as,
m eningiom as,  acoust ic  neurom as) .  The  plots  showed  data  are  not  norm ally
dist r ibuted and therefore to com pare m eans between cases and cont rols, non-
param etr ic test  was used. I n figure 3.1.1 is the distr ibut ion of total elect rom agnetic
field  exposure  calculated  by  SOC codes  am ong  all  part icipants  and  in  figure  3.1.2
the  dist r ibut ion  of  total  elect rom agnet ic  field  exposure  calculated  by  SI C  codes
am ong all part icipants.  The dist ribut ions of total elect rom agnet ic field exposure by
SOC  codes  am ong  cases  and  cont rols  dem onst rated  in  figure  3.1.3  and  am ong
cases subtypes (gliom as, m eningiom as, acoust ic neurom as)  and cont rols in figure
3.1.4.  Figure  3.1.5  shows the  dist ribut ions  of  total  electrom agnet ic  field  exposure
by  SI C  codes  am ong  cases  and  cont rols  and  figure  3.1.6  am ong  cases  subtypes
(gliom as, meningiom as, acoust ic neurom as)  and cont rols.
Figure 3 .1 .1  Distr ibut ion of total e lectrom agnet ic fields exposure by SOC
codes among all par t icipants
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Figure 3 .1 .2  Distr ibut ion of total e lectrom agnet ic field ( EMF)  exposure by
SI C codes am ong a ll par t icipants
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Figures 3 .1 .3  Dist ribut ion of total e lectrom agnet ic field exposure by SOC
codes among cases and controls
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Figures 3 .1 .4  Dist ribut ion of total e lectrom agnet ic field exposure by SOC
codes among cases subtypes ( gliom as, m eningiom as, acoust ic neurom as)
and controls
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Figures 3 .1 .5  Dist ribut ion of total e lectrom agnet ic field exposure by SI C
codes among cases and controls
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Figures 3 .1 .6  Dist ribut ion of total e lectrom agnet ic field exposure by SI C
codes among cases subtypes ( gliom as, m eningiom as, acoust ic neurom as)
and controls
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Table 3.3 shows the stat ist ic for cumulat ive electrom agnet ic f ield exposure
est im ates based on the two m ethods, indust ry or  occupat ional classificat ion. In our
analysis  for  cumulat ive  exposure  to  elect rom agnet ic  fields  by  occupat ion  (by  SOC
code)  and the r isk of developing brain tum ours, the SOC code 9129 (12 subjects of
the total  9992  job  subjects)  was excluded as after  m atching  this specific code with
the  US80  code,  the  geom etr ic  m ean  (GM)  for  this  code  was  ext rem ely  high
(593,403) ,  and  including  the  values  in  the  dataset  obviously  would  create  a  large
standard  deviat ion  around  the  means.  The  percentage  of  missing  data  for  SI C
codes is 6.05%  and for SOC codes is 3.39% . Com paring the medians of cumulat ive
elect rom agnet ic fields exposure by indust ry, all cases, gliom as and acoust ic
neurom as had  a  sm aller  m edian  than  the  one  of  controls.  The  m edian  of  acoust ic
neurom as has t he higher dif ference com pared to the m edian of cont rols (acoust ic
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neurom as:  m edian 613.99 –controls:  m edian 749.320) . The m edian of exposure
for m eningiom as is approxim ately the sam e with the one of cont rols.
For cumulat ive EMF exposure by occupat ion, gliom a cases had higher m edian value
than cont rols (Gliomas:  m edian 827.600 – Cont rols:  m edian 804.256) .
Meningiom as had a higher m edian than cont rols (Meningiom as:  median 811.573 –
Cont rols:  m edian  804.256) .  The  median  of  acoust ic  neurom as  was  sm aller
com pared to the one of cont rols (Acoust ic neuromas:  median 709.280 – Cont rols:
m edian  804.256) .  There  was  no  difference  between  the  Standard  Occupat ional
Classificat ion (SOC)  and the Standard I ndust rial Classificat ion (SI C)
elect rom agnet ic  fields  (EMF)  exposure  m eans  for  the  case  and  cont rol  groups
(Mann-Whitney U test ,  p-value > 0.05) .
Table 3 .3 . Stat ist ics of cum ulat ive electrom agnet ic field ( EMF)  exposures
by SI C and SOC codes
All cases
( n= 9 70 )
Gliom a
( n= 5 88 )
Meningiom a
( n= 2 47 )
Acoustic
Neurom a
( n= 1 35 )
Control
( n= 1 09 7 )
EMFSI C
  Mean
  Median
  Min
  Max
  SD
  Missing
908.061
718.241
4.004
16898.830
1311.964
13
971.532
725.332
4.004
16898.830
1559.521
6
791.535
750.035
40.040
4251.938
479.929
4
842.726
613.399
4.505
12227.740
1140.890
3
933.060
749.320
22.880
21238.360
1315.033
12
EMFSOC
  Mean
  Median
  Min
  Max
  SD
 Missing
957.758
809.261
0.000
10578.660
808.510
9
976.321
827.660
23.786
8947.663
798.665
6
912.937
811.573
0.000
4370.044
619.077
3
958.745
709.280
8.366
10578.660
1103.315
0
928.940
804.256
0.000
10743.030
722.919
10
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Table 3.4 shows the frequency numbers for  the diagnosis groups ( cont rols,  all
cases, gliom as, m eningiom as, acoust ic neurom as)  by SI C and SOC based on
quart iles dist r ibut ion.  Cut -off  points for  EMF exposure  quart iles were  based  on  the
frequency  of  EMF exposure  in  the  cont rols  subjects.  The  lowest  quart ile  (Q1)  was
the reference category.  For  total  EMF exposure  by  indust ry  and  by  occupat ion  the
distr ibut ion in the first  quart ile is higher  than in the other  ones for  all cases and for
gliom as,  m eningiom as  and  acoust ic  neurom as  (Total  EMF  SI C  -  Q1:  all  cases
28.8% , gliom as 28,2% , m eningiom as 26,7% , acoust ic neurom as 35,6% , Total EMF
SOC – Q1:  all cases 26,3% , gliom as 23,5% , m eningiom as 27% , acoust ic neurom as
37% ) . Especially for  acoust ic neurom as the dist r ibut ion in the first  quart ile for  total
EMF exposure by indust ry and by occupat ion is very high than in the others
quart iles. This abnormality to the dist ribut ion m ight  influence our results.
Table 3 .4 . Frequency num bers for diagnosis groups by sic and soc codes in
quart iles
All cases Gliom a Meningiom a Acoustic
Neurom a
Control
TEMFSI C
 Q1
 Q2
 Q3
 Q4
 Total
Missing:  25 (1,2% )
276 (28,8)
234 (24,5)
227 (23,7)
220 (23,0)
957 (100)
13
164 (28,2)
147 (25,3)
133 (22,9)
138 (23,7)
582 (100)
6
65 (26,7)
56 (23,0)
68 (28,0)
54 (22,2)
243 (100)
4
47 (35,6)
31 (23,5)
26 (19,7)
28 (21,2)
132 (100)
3
271 (25,0)
271 (25,0)
272 (25,1)
271 (25,0)
1085 (100)
12
TEMFSOC
(9129 excluded)
 Q1
 Q2
 Q3
 Q4
 Total
Missing:  19 (0,9% )
253 (26,3)
224 (23,3)
241 (25,1)
243 (25,3)
961 (100)
9
137 (23,5)
141 (24,2)
153 (26,3)
151 (25,9)
582 (100)
6
66 (27,0)
55 (22,5)
63 (25,8)
60 (24,6)
244 (100)
3
50 (37,0)
28 (20,7)
25 (18,5)
32 (23,7)
135 (100)
0
271 (24,9)
272 (25,0)
272 (25,0)
272 (25,0)
1087 (100)
10
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Tables 3.5 (3.5.1-3.5.8)  show the dist ribut ion of subjects by Standard Industr ial
Classificat ion (SI C)  and Standard Occupat ional Classificat ion (SOC)  codes based on
quart iles dist ribut ion and the est im ated risks for  the occupat ional and indust rial
exposure to elect rom agnet ic fields (EMF) .  The lowest  quart ile (Q1)  was used as
the reference category.   For  total elect rom agnet ic field (EMF)  exposure by  industry
and by occupat ion, the distr ibut ion of cases in the first  quart ile is the highest
regardless of tum our type.
Table  3.5.1  showed  the  result s  for  all  brain  tum our  cases  and  the  exposure  to
elect rom agnet ic fields by  industry  (by  SI C) .  The unadjusted  crude odd  rat ios even
though indicate a weak inverse associat ion between elect rom agnet ic f ield exposure
and brain tum ours were not  stat ist ically significant  (p-value> 0.05) . When the
elect rom agnet ic field exposure increases, the r isk of developing brain tum our
slight ly decreases (Q2:  OR 0.85, 95%  CI  (0.67-1.08) , p-value 0.182 – Q3:  OR
0.82, 95%  CI  0.64-1.05, p-value 0.109 and Q4:  OR 0.79, 95%  CI  0.62-1.01, p-
value 0.069) .  A m odest  stat ist ically  significant  decreased  r isk  was observed  in  the
3 rd and  4 t h quart ile for adjusted m odel results for elect rom agnet ic fields exposure
by indust ry (by SI C)  (Q3:  OR 0.73, 95%  CI  0.55-0.97 and Q4:  OR 0.70, 95%  CI
0.52-0.94) .  There  was evidence of  risk  decreasing  across all  quart iles (p  for  t rend
0.019) .
3 .5 .1  Total  EMF exposure classified by SI C codes and all brain tum ours r isk
EMF
exposure
Control
(n= 1085)
Case
(n= 957)
Crude OR
 (95%  CI )
p-value
Adjusted OR
(95%  CI )£
p-value
Q1 271 276 1.00 1.00
Q2 271 234 0.85 (0.67-1.08) 0.182 0.80 (0.62-1.05) 0.103
Q3 272 227 0.82 (0.64-1.05) 0.109 0.73 (0.55-0.97) 0.032
Q4
p- t rend
271 220 0.79 (0.62-1.01) 0.069 0.70 (0.52-0.94) 0.017
0.019
£
 Adjusted for age ( in 5-year groups) , sex, study region, deprivat ion category (Townsend score
reflect ing social status)
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Table  3.5.2  showed  the  results  for  gliom as and  their  associat ion  with  exposure  to
elect romagnet ic fields by indust ry (by SI C) . For the unadjusted model even though
there was a weak inverse associat ion between exposure and the risk of developing
gliom a the odd rat ios were not  stat ist ically  significant  (Q2:  OR 0.89,  95%  CI  0.68-
1.18, p-value 0.442 –Q3:  OR 0.81, 95%  CI  0.61-1.07, p-value 0.141 and Q4:  OR
0.84, 95%  CI  0.64-1.12, p-value 0.231) . The adjusted odd rat ios showed that
part icipants with exposure to elect rom agnet ic fields in the 3 rd quart ile are 28%  less
likely  to  develop  gliom a  and  for  those  in  the  4 th quart ile  29%  less  likely  (Q3:  OR
0.72, 95%  CI  0.51-1.01 and Q4:  OR 0.71, 95%  CI  0.45-1.00) . A clear t rend of r isk
reduct ion across quart iles was obtained (p for  t rend 0.03) .
3 .5 .2  Total EMF exposure classified by SI C codes and r isk of developing gliom as
EMF
exposure
Control
(n= 1085)
Case
(n= 582)
Crude OR
 (95%  CI )
p-value
Adjusted OR
(95%  CI )£
p-value
Q1 271 164 1.00 1.00
Q2 271 147 0.89 (0.68-1.18) 0.442 0.87 (0.64-1.19) 0.402
Q3 272 133 0.81 (0.61-1.07) 0.141 0.72 (0.51-1.01) 0.059
Q4
p- t rend
271 138 0.84 (0.64-1.12) 0.231 0.71 (0.45-1.00) 0.049
0.034
£
 Adjusted for age ( in 5-year groups) , sex, study region, deprivat ion category (Townsend score
reflect ing social status)
Table 3.5.3 shows the results obtained for elect rom agnet ic field exposure by
indust ry and the risk to develop m eningiom a. No associat ion was found between
exposure to electrom agnetic fields (by SI C)  and m eningiom as. The unadjusted and
adjusted  odd  rat ios were  not  stat ist ically  significant ,  as well  as the  p  for  t rend  (p-
t rend= 0.44> 0.05) . For t he unadjusted m odel the results for the 2 nd quart ile were
Q2:  OR 0.86, 95%  CI  0.58-1.28, p-value 0.460, for  the 3rd quart ile Q3:  OR 1.04,
95%  CI  0.71-1.52, p-value 0.830 and for the 4 t h quart ile Q4:  OR 0.83, 95%  CI
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0.56-1.24,  p-value 0.362.  For  the adjusted m odel even though the odd rat ios were
indicat ing  that  exposure  to  elect rom agnet ic  fields  decrease  the  r isk  of  developing
m eningiom as,  the  result s  were  not  stat ist ically  significant  (Q2:  OR 0.74,  95%  CI
0.48-1.13, p-value 0.157 – Q3:  OR 0.87, 95%  CI  0.56-1.36, p-value 0.550 and
Q4:  OR 0.77, 95%  CI  0.48-1.24, p-value 0.283).
3 .5 .3  Total EMF exposure classified by SI C codes and r isk of developing m eningiom as
EMF
exposure
Control
(n= 1085)
Case
(n= 243)
Crude OR
 (95%  CI ) p-value
Adjusted OR
(95%  CI )£ p-value
Q1 271 65 1.00 1.00
Q2 271 56 0.86 (0.58-1.28) 0.460 0.74 (0.48-1.13) 0.157
Q3 272 68 1.04 (0.71-1.52) 0.830 0.87 (0.56-1.36) 0.550
Q4
p- t rend
271 54 0.83 (0.56-1.24) 0.362 0.77 (0.48-1.24) 0.283
0.44
£
 Adjusted for age ( in 5-year groups) , sex, study region, deprivat ion category (Townsend score
reflect ing social status)
Table 3.5.4 dem onst rates the result s for  elect rom agnet ic field exposure by indust ry
(by  SI C)  and the risk  factor  to develop  acoust ic neurom as.  For  acoust ic neurom as,
the unadjusted m odel showed the inverse associat ions in the 3 rd and  4 t h quart ile
(Q3:  OR 0.55, 95%  CI  0.33-0.92 and Q4:  OR 0.59, 95%  CI  0.36-0.98) . Crude odd
rat ios  showed  that  exposure  to  elect rom agnet ic  fields  seem  to  be  protect ive,  as
subjects who are in the quart iles with the high exposure are 45%  ( for  3rd quart ile)
and  41%  ( for  4 t h quart ile)  less  likely  to  develop  acoust ic  neurom as.  The  effects
disappeared when adjusted for confounding factors, as the adjusted odd rat ios
were not  stat ist ically significant  (Q3:  OR 0.59, 95%  CI  0.33-1.06, p-value 0.083
and Q4:  OR 0.67, 95%  CI  0.37-1.23, p-value 0.198) . Collect ively, there was no
evidence of risk decreasing across quart iles (p for t rend 0.185) .
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3 .5 .4  Total EMF exposure classified by SI C codes and r isk of developing acoust ic
neurom as
EMF
exposure
Control
(n= 1085)
Case
(n= 132)
Crude OR
 (95%  CI ) p-value
Adjusted OR
(95%  CI )£ p-value
Q1 271 47 1.00 1.00
Q2 271 31 0.66 (0.41-1.07) 0.092 0.66 (0.39-1.11) 0.116
Q3 272 26 0.55 (0.33-0.92) 0.021 0.59 (0.33-1.06) 0.083
Q4
p- t rend
271 28 0.59 (0.36-0.98) 0.041 0.67 (0.37-1.23) 0.198
0.185
£
 Adjusted for age ( in 5-year groups) , sex, study region, deprivat ion category (Townsend score
reflect ing social status)
Table  3.5.5  indicates  the  result s  for  all  brain  tum our  cases  and  the  exposure  to
elect rom agnet ic fields by  occupat ion  (by  SOC) .  The unadjusted  odd  rat ios showed
no associat ion (Q2:  OR 0.88, 95%  CI  0.69-1.13, p-value 0.318 – Q3:  OR 0.95,
95%  CI  0.74-1.21, p-value 0.674 and Q4:  0.96, 95%  CI  0.75-1.22, p-value
0.723) .  Also,  for  adjusted  m odel  no  associat ion  was observed  (Q2:  OR 0.86,  95%
CI  0.66-1.12, p-value 0.257 – Q3:  OR 0.91, 95%  CI  0.69-1.21, p-value 0.510 and
Q4:  OR 0.91, 95%  CI  0.68-1.22, p-value 0.531). Overall,  no stat ist ically significant
associat ions were found between exposure to elect rom agnet ic fields by Standard
Occupat ional classificat ion (SOC)  coding and brain tum ours.  Also there was no
evidence of risk across quart iles (p- t rend 0.70) .
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3 .5 .5  Total EMF exposure classified by SOC codes and brain tumours r isk
EMF
exposure
   Cont rol
(n= 1087)
Case
(n= 961)
Crude OR
 (95%  CI ) p-value
   Adjusted OR
(95%  CI )£ p-value
Q1 271 253 1.00 1.00
Q2 272 224 0.88 (0.69-1.13) 0.318 0.86 (0.66-1.12) 0.257
Q3 272 241 0.95 (0.74-1.21) 0.674 0.91 (0.69-1.21) 0.510
Q4
p- t rend
272 243 0.96 (0.75-1.22) 0.723 0.91 (0.68-1.22) 0.531
0.70
£
 Adjusted for age ( in 5-year groups) , sex, study region, deprivat ion category (Townsend score
reflect ing social status)
For the subgroup of gliom as and the associat ion with exposure to elect rom agnet ic
fields by  occupat ion (by  SOC)  no stat ist ically  significant  result s were observed (see
table 3.5.6) . I n unadjusted and adjusted models exposure t o elect romagnetic fields
was not  associated  with  a risk  of  developing  gliom a.  For  unadjusted  odd rat ios the
results were Q2:  OR 1.03, 95%  CI  0.77-1.37, p-value 0.865 – Q2:  OR 1.11, 95%
CI  0.84-1.48, p-value 0.463 and Q4:  OR 1.10, 95%  CI  0.83-1.46, p-value 0.463) .
For  adjusted  odd  rat ios the  result s were  for  the  2nd quart ile Q2:  OR 1.03, 95%  CI
0.74-1.42, p-value 0.868 – for  the 3 rd quart ile Q3:  OR 1.07, 95%  CI  0.76-1.51, p-
value 0.685 and for  the 4 t h quart ile Q4:  OR 1.04, 95%  CI  0.73-1.48, p-value
0.835. A non-stat ist ically significant  p for t rend across the quart iles (p-t rend 0.81)
shows no risk across the quart iles (see table 3.5.6) .
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3 .5 .6  Total EMF exposure classified by SOC codes and r isk of developing gliom as
EMF
exposure
Cont rol
(n= 1085)
Case
(n= 582)
Crude OR
 (95%  CI ) p-value
Adjusted OR
(95%  CI )£ p-value
Q1 271 137 1.00 1.00
Q2 272 141 1.03 (0.77-1.37) 0.865 1.03 (0.74-1.42) 0.868
Q3 272 153 1.11 (0.84-1.48) 0.463 1.07 (0.76-1.51) 0.685
Q4
p- t rend
272 151 1.10 (0.83-1.46) 0.521 1.04 (0.73-1.48) 0.835
0.81
£
 Adjusted for age ( in 5-year groups) , sex, study region, deprivat ion category (Townsend score
reflect ing social status)
Sim ilar result s were obtained with m eningiom as and their associat ion with
exposure to elect rom agnet ic fields by occupat ion (by SOC)  (see table 3.5.7) . No
associat ion was observed between elect rom agnet ic field exposure and the r isk of
developing m eningiom as.  The unadjusted crude odd rat ios were for  the 2nd quart ile
Q2:  OR 0.83, 95%  CI  0.56-1.23, p-value 0.357, for  the 3rd quart ile Q3:  OR 0.95,
95%  CI  0.65-1.40, p-value 0.798 and for  the 4 t h quart ile  Q4:  OR  0.91,  95%  CI
0.61-1.34, p-value 0.617.  The adjusted odd rat ios were for the 2nd quart ile Q2:  OR
0.75, 95 %  CI  0.49-1.15, p-value 0.182, for  the 3 rd quart ile  Q3:  OR 0.91,  955  CI
0.58-1.14, p-value 0.662 and for  the 4 t h quart ile Q4:  OR 0.85, 95%  CI  0.54-1.34,
p-value  0.491.  The  odd  rat ios  were  not  stat ist ically  significant  for  unadjusted  and
adjusted m odel, as well as the p for t rend (p- t rend 0.713)  (see table 3.5.7) .
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3 .5 .7  Total EMF exposure classified by SOC codes and r isk of developing m eningiom as
EMF
exposure
Control
(n= 1085)
Case
(n= 244)
Crude OR
 (95%  CI ) p-value
Adjusted OR
(95%  CI )£ p-value
Q1 271 66 1.00 1.00
Q2 272 55 0.83 (0.56-1.23) 0.357 0.75 (0.49-1.15) 0.182
Q3 272 63 0.95 (0.65-1.40) 0.798 0.91 (0.58-1.41) 0.662
Q4
p- t rend
272 60 0.91 (0.61-1.34) 0.617 0.85 (0.54-1.34) 0.491
0.713
£
 Adjusted for age ( in 5-year groups) , sex, study region, deprivat ion category (Townsend score
reflect ing social status)
With acoust ic neurom as, the significant  risk reduct ions were observed in the 2nd
and  3 rd quart ile for  both unadjusted and when adjusted for  confounding factors
(Q2:  crude OR 0.56, 95%  CI  0.34-0.91, adjusted OR 0.53, 95%  CI  0.31-0.90, Q3:
crude OR 0.50, 95%  CI  0.30-0.83, adjusted OR 0.52, 95%  CI  0.29-0.93) . I n the
4 t h quart ile  r isk  reduct ions  were  observed  too  for  both  unadjusted  and  adjusted
m odel, but  they were not  stat ist ically significant  (Q4:  crude OR 0.64, 95%  CI  0.40-
1.03, p-value 0.063 – adjusted OR 0.72, 95%  CI  0.41-1.28, p-value 0.263) .
Nevertheless,  there  was  no  clear  t rend  of  r isk  reduct ion  (p  for  t rend  0.287)  (see
table 3.5.8) .
3 .5 .8  Total EMF exposure classified by SOC codes and r isk of developing acoust ic
neurom a
EMF
exposure
Control
(n= 1085)
Case
(n= 135)
Crude OR
 (95%  CI ) p-value
Adjusted OR
(95%  CI )£ p-value
Q1 271 50 1.00 1.00
Q2 272 28 0.56 (0.34-0.91) 0.020 0.53 (0.31-0.90) 0.018
Q3 272 25 0.50 (0.30-0.83) 0.007 0.52 (0.29-0.93) 0.026
Q4
p- t rend
272 32 0.64 (0.40-1.03) 0.063 0.72 (0.41-1.28) 0.263
0.287
£
 Adjusted for age ( in 5-year groups) , sex, study region, deprivat ion category (Townsend score
reflect ing social status)
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Overall, a m odest  stat ist ically  significant  decreased r isk  was observed in the 3 rd and
4 t h quar t ile for adjusted model results for elect romagnet ic fields exposure by
indust ry  (by  SI C)  and  the  risk  of  brain  tum ours  (Q3:  OR 0.73,  95%  CI  0.55-0.97
and Q4:  OR 0.70, 95%  CI  0.52-0.94) . There was evidence of risk decreasing
across all  quart iles (p  for  t rend  0.019) .  Sim ilar  results were  observed  for  adjusted
odd  rat ios  for  electrom agnet ic  fields  exposure  by  indust ry  and  the  risk  to  develop
gliom as (Q3:  OR 0.72, 95%  CI  0.51-1.01 and Q4:  OR 0.71, 95%  CI  0.45-1.00) . A
clear  t rend  of  r isk  reduct ion  across  quart iles  was  obtained  (p  for  t rend  0.03) .  No
associat ion  was  found  between  exposure  to  elect rom agnet ic  fields  (by  SI C)  and
m eningiom as. For acoust ic neurom as, even though the unadjusted m odel showed
the inverse associat ions in the 3rd and 4 t h quart ile (Q3:  OR 0.55, 95%  CI  0.33-0.92
and  Q4:  OR 0.59,  95%  CI  0.36-0.98) ,  the  effects  disappeared  when  adjusted  for
confounding factors.
No  stat ist ically  significant  associat ions  were  found  between  exposure  to
elect rom agnet ic fields by Standard Occupat ional classificat ion (SOC)  coding and
brain  tum ours.   Also there was no evidence of  risk  across quart iles (p- t rend 0.70) .
Sim ilar  results also obtained with gliom as and meningiom as. With acoust ic
neurom as, the significant  r isk reduct ions were observed in the 2nd and  3rd quart ile
for  both unadjusted and when adjusted for  confounding factors (Q2:  crude OR
0.56, 95%  CI  0.34-0.91, adjusted OR 0.53, 95%  CI  0.31-0.90, Q3:  crude OR 0.50,
95%  CI  0.30-0.83, adjusted OR 0.52, 95%  CI  0.29-0.93) . Nevertheless, there was
no clear t rend of risk reduct ion (p for trend 0.287) .
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4 . Discussion for  results on occupat ional e lect rom agnetic fie ld exposure
and the r isk of developing brain tum ours
Sum m ary of f indings
This study is a m ult i-cent re large case-cont rol study which aim s to address the
effect  of  low  frequency  elect rom agnet ic  fields  (LFEMF)  on  brain  tum ours.  I t
presents the results for all brain tum our cases as well as a break down by subtype;
gliom as, m eningiom as, and acoust ic neurom as and their  associat ion with
cumulat ive  exposure  to  elect rom agnet ic  fields  est im ated  either  by  Standard
I ndust ry Classif icat ion (SI C)  or  by Standard Occupat ional Classificat ion (SOC)
codes. The findings suggest  that  cumulat ive exposure according to the Standard
I ndust ry  Classificat ion  (SI C)  is inversely  associated  with  all  cases of  brain  tum our.
The  significant  r isk  reduct ions  were  observed  in  the  3rd and  4 t h quart ile com pared
to  the  1st quart ile (approxim ately by 30%  r isk reduct ion) .  There is evidence of a
decrease  in  r isk  across  quart iles  (p  for  t rend  0.019) .   Similar  result s  were  seen
with gliom as (p for  t rend 0.03) .   For  m eningiomas and acoust ic neurom as,  none of
the result s were stat ist ically  significant .  On  the cont rary,  on  analysis of  cum ulat ive
EMF exposure by the Standard Occupat ional Classificat ion (SOC), the protect ive
effects were observed in the 2nd and  3rd quart ile for  the acoust ic neurom a group
only  ( risk  reduct ion  of  50% ) .  There  was,  however,  no  clear  t rend  of  risk  reduct ion
for all quart iles.
Com parison w ith other literature
The study  findings were not  in  keeping with m ost  of  the previous lit erature.   There
are studies suggest ing associat ion between elect rom agnet ic fields exposure and
brain  tum ours  and  some  others  reported  no  associat ion.  But  there  is  no  evidence
that  elect rom agnet ic field exposure plays a protect ive role in adults’ brain tum ours.
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Com parison with studies of sim ilar exposure
As  we  have  m ent ioned  above,  lim ited  data  exist  regarding  associat ion  between
occupat ional  exposure  to  elect rom agnet ic  fields  and  brain  tum ours.  All  previous
studies were looking at  specific exposure to elect rom agnet ic f ields,  especially
among elect r ic occupat ions, rather than lifet im e exposure to electrom agnet ic fields.
Therefore there is no evidence of lifet im e occupat ional exposure t o elect romagnetic
fields and the risk of having brain tum our.
Com par ison with case-cohort  and cohort -mortalit y  studies
There are four studies support ing that  elect romagnet ic fields exposure might  play a
role  in  the  development  of  brain  tum ours.  I n  a  case-cohort  study  (145  cases/ 800
cont rols,  0.6%  of  the  cohort -workers  of  elect r ic  power  com panies  in  the  US)
assessed m agnet ic field exposure with the risk  of  brain tum ours an augmented r isk
was obtained  ( risk  rat io  for  average  exposure:  RR 2.5,  95%  CI  1.0-6.3,  r isk  rat io
for  cumulat ive exposure:  RR 1.8, 95%  CI  0.7-4.7)  (Savitz et  al 2000) . A refined
m agnet ic field job-exposure m atr ix was used to est im ate the exposure in this
study.  A  cohort  m ortalit y  study  of  138,905  workers  of  5  large  elect ric  power
com panies  in  the  US  reported  a  brain  tum our  m ortality  rate  rat io  of  2.6  in  the
highest  exposure category and an increased r isk of developing the disease (by 1.94
per  microtesla-year  of  m agnet ic  field  exposure)  (Savit z  &  Loom is  1995) .  In  this
study, the exposure was est im ated by linking individual work histories to data from
2,842 work shift  m agnet ic m easurem ents and death rates analysed with Poisson
regression. Theriault  et  al in a cohort -case study (60 brain tum ours cases out  of
223,200 em ployees)  found that  workers with exposure in the 90 t h percent ile  of
cumulat ive  exposure  >  15.7  microtesla  (µT) -years have a  non-significant  increase
r isk to develop brain tum ours (OR 1.95, 95%  CI  0.76-5.00) , but  there was no
elevated  risk  for  glioblastom as  (Theriault  et  al  1994) .   Est im at ion  of  cumulat ive
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exposure  for  this  study  was  obtained  from  m easurem ents  of  2,066  workers
performing tasks sim ilar  to those in cohorts using personal dosimeters. The
st rongest  risks were shown in Preston-Mart in et  al study invest igat ing exposure to
elect rom agnet ic  fields  and  the  r isk  of  brain  tum ours  am ong  electr icians  (OR 4.6,
95%  CI  1.7-2.2)  and elect rical engineers (OR 8.2, 95%  CI  20-34.7)(Preston-Mart in
et  al 1993) .  This study uses com pletely different  m ethods, as it ’s invest igat ing the
pat tern  of  occurrence of  brain  tum ours (5,  684  cases)  by  occupat ion  and there are
no m easurem ents or calculat ion of elect romagnet ic field exposure. Only the cohort -
m ortalit y  study (83,997 em ployees of the form er Central Elect r icit y  Generat ing
Board of England and Wales)  by Sorahan (2001) ,  showed a highly significant
negat ive  t rend  of  r isk  decreasing  with  increasing  EMF  exposure  (p< 0.001) ,
although  m ost  point  est im ates  of  r isk  were  close  to  unit y  (Sorahan  et  al  2001) .
This  study  used  com puter ized  work  histories  for  79,972  subjects  and  a  detailed
calculat ion  of  the  exposure  was  performed  by  others.  All  these  studies  showing
that  exposure  to  electrom agnet ic  fields  might  be  associated  with  brain  tum ours
have  different  sam ple  size  compared  to  our  study.  The  sm all  num ber  of  cases
com pared  to  the  controls  that  these  studies  have  reduces  the  power  of  the
evidence. Most  of the previous studies assessed exposure based on one high
exposed job t it le,  par t icular ly  am ong electr ic workers.  I n this study all possible jobs
were taken  into account .   Most  of  these studies used only  measurements obtained
with  personal  dosim eters  for  the  est im at ion  of  the  exposure  and  there  was  no
est im at ion of the exposure by SI C or SOC codes.
I n  som e  of  the  studies  no  associat ions  were  observed  (Johansen  and  Olsen  1998,
Harrington  et  al  1997,  Sorahan  et  al  2001,  Johansen  and  Olsen  2007) .  In  the
Johansen  and  Olsen  (1998)  cohort  study  (32  006  workers/  57  m en  cases  and  15
wom en cases observed)  the results do not  support  an associat ion (non-significant
standard incidence rat io 0.8 (95%  CI  0.6-1.0)  for  m en and 1.3 (95%  CI  0.7-  2.2)
for  wom en)  (Johansen and Olsen 1998) .  Similar  result s obtained by another cohort
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study. A non-significant  standard incidence rat io 0.7 (95%  CI  0.4-1.3)  observed for
m en and a stat ist ically  significant  increase standard incidence rat io 1.4 (95%  CI
0.5-  3.7)  for  wom en,  but  could  not  support  the  hypothesis  as  the  num ber  of
wom en cases observed in cohort  was very  sm all (Johansen and Olsen 2007) .  From
a  m ortalit y-cohort  study  of  84,018  m ale  and  fem ale  em ployees  of  Central
Electr icit y  Generat ing Board no associat ion was observed neither between subjects
with lower exposures to m agnet ic fields (0.0-5.3 microT.y)  nor between subjects
with higher exposures (>  or  =  13.5 microT.y) .  The  risk  of  m ortalit y  was
respect ively 1.04 (95%  CI  0.60-  1.80)  and 0.95 (95%  CI  0.54 -  1.69)  and there
was no evidence of increase t rend for  cumulat ive exposure and the r isk of m ortalit y
for  brain tum ours (Harrington et  al 1997) . Com paring these studies with our study,
the  sam ple  size  of  the  cases  is  very  sm all  com pared  to  the  cont rols  and  no
hypothesis can be supported. The two cohort  studies by Johansen and Olsen used
only occupat ional exposure m at rix (no indiv idual m easurem ents)  for  obtaining the
elect rom agnet ic field exposure, therefore the est im at ion of the exposure m ight  not
be accurate.
Com parison with case-cont rol studies
The study  findings are  not  in  keeping  as well  with  result s of  previous case-cont rol
studies. Three case-cont rol studies reported increase risk between elect rom agnet ic
fields exposure and brain tum ours. A case-cont rol study (261 cases-1211 cont rols)
conducted  in  Sweden  suggests  a  relat ive  sm all  increase  risk  of  all  brain  tum ours.
The r isk est im ates were 1.0 (95%  CI  =  0.7-1.6) ;  1.5 (95%  CI  =  1.0-2.2) ;  1.4
(95%  CI  =  0.9-2.1)  respect ively  for  three  consecut ive  levels  of  occupat ional
exposure to low- frequency elect rom agnet ic fields (Floderus et  al 1993) .  Est im at ion
of  the  exposure  was  based  on  m easurem ents  from  1,015  different  workplaces
am ong  elect ric  workers.  The  sam ple  size  of  cases  com pared  to  the  cont rols  in
Floderus et  al study  is not  big enough and this fact  reduces the power  of  evidence.
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Also,  the assessment  of  the exposure is based on a high exposure job t it le,  electr ic
workers, com pared to our study where all possible jobs were taken into account .
A case-cont rol  study  (84  gliom as,  20  m eningiom as and  155  cont rols)  reported  an
increase r isk for m eningiom as when analysis was based on “elect rical occupat ions”
(Relat ive risk  1.8,  95%  CI :  0.3-3.6)  and an increase risk  for  gliom as when analysis
based on  exposure measurements (Relat ive risk  1.9,  95%  CI :  0.8-5.0)  (Rodvall  et
al 1998) .  These results do not  have st rong power  as the sample size,  especially  for
m eningiom as,  is  very  sm all.  The  m ethodology  used  in  this  study  is  similar  to  the
one of  our  study,  as occupat ion  quest ionnaires and  individual  measurements were
taken  into account  for  the calculat ion  of  the exposure.  Also,  the assessm ent  of  the
exposure was based on all possible jobs. Nevertheless, there was no separate
evaluat ion of exposure by SI C or SOC codes.
A populat ion-based case-control study (543 cases-543 cont rols)  invest igated the
relat ion  between  occupat ional  exposure  to  m agnet ic  fields  and  brain  tum ours  in
m en  (Villeneuve  et  al  2002) .  Even  though  an  increase  risk  observed  for
part icipants  who  had  ever  worked  in  a  job  with  an  exposure  > 0.6  m icroT (OR =
1.33, 95%  CI :  0.75-2.36)  the results were not  stat ist ically significant ,  but  a
stat ist ically significant  augm ented r isk obtained am ong glioblastom as cases (OR =
5.36,  95%  CI :  1.16-24.78) .  The sam ple size of  cases and cont rols is big enough to
provide  sufficient  power  for  this  study.  Nevertheless,  the  exposure  was  not
assigned in this study using occupat ional coding, as we did in our study. An
exposure value based on a t im e-weighted average (TWA)  was used for the
est im at ion, com pared to the geom etr ic m eans we used for the calculat ion of the
exposure. This study took into account  all job t it les as we did in our study but  there
was no est im at ion of exposure by SI C or SOC codes separately.
I n a recent  case-cont rol study (414 cases-421 cont rols)  Karipidis et  al found
elevated  but  non-significant  r isks for  all  gliom as (OR 1.4,  95%  CI :  0.85-2.27)  and
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for  high  grade  gliom as  (OR  1.51,  95%  CI :  0.90-2.53)  when  low  frequency
occupat ional exposure to magnet ic f ields was assessed with an expert  hygienist
(Karipidis  et  al  2007) .  On  the  other  hand,  Karipidis  et  al  study  reported  inverse
associat ion  between  low  and  high  grade  gliom as and  exposures  assessed  by  self-
report  and job exposure m atr ix  (JEM) .  In addit ion,  another  case-cont rol study  (454
cases – 908 cont rols)  showed an inverse relat ion risk between occupational
exposure  to  50  Hz and  brain  tum ours (RR 0.6,  95%  CI  0.3-0.9) ,  but  these result s
were  not  supported  with  a  stat ist ically  significant  p-value  (Klaeboe  et  al  2005) .
These two studies are the only ones that  obtained non-significant  decreased risks
of brain tum ours when the elect rom agnet ic field exposure was increasing, even
though  their  result s  do  not  support  a  role  of  occupat ional  elect rom agnet ic  field
exposure in t he developm ent  of brain tum ours. These studies have sufficient  power
of  result s  as  they  invest igate  a  big  size  sam ple  and  they  follow  similar  methods
with our study ( job exposure m at rix) .  None of these two studies calculate the
exposure by SI C and SOC codes separately.
Overall sum m ary
Overall,  the evidence that  occupat ional exposure t o electrom agnet ic fields plays a
role in the development  of brain tum ours is weak. Even though, som e exist ing data
indicate  an  associat ion  between  elect rom agnet ic field  exposure  and  the disease,  it
is  not  yet  clear  enough  whether  electrom agnet ic  field  exposure  is  a  potent ial  risk
factor for  brain tum ours. The findings of the study are not  in com m on with m ost  of
the results observed from  previous invest igat ions. Only two case-cont rol studies
reported  that  exposure  to  elect rom agnet ic  fields  cause  a  decreased  r isk  for  brain
tum ours,  but  the  results  are  not  stat ist ically  significant  and  do  not  support  any
associat ion (Klaeboe et  al 2005, Kar ipidis et  al 2007) .
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Strengths and Lim itat ions of the study
This  study  is  one  of  the  biggest  case-control  studies  conducted.  The  total  number
of  2067  subjects (970  cases and 1097  cont rols)  that  was included in  the stat ist ical
analysis (gliom as n= 588;  m eningiom as n= 247;  acoust ic neurom as n= 135;
cont rols= 1097)  allow  us  to  produce  robust  evidence  of  r isk,  based  on  stat ist ically
significant  result s.  The  case  response  for  this  study  was  very  high  for  a  cancer
case-cont rol  study  (63%  for  gliom as,  81%  for  m eningiom as and  89%  for  acoust ic
neurom as) ,  and  therefore  the  case  sample  was  representat ive  and  unbiased.  This
study  suffers  from  low  part icipat ion  of  controls  (44% ) .  This  is  very  com m on  for
m any populat ion-based case-cont rol studies. Due to ethical const raints, cont rols
were approached and recruited through their  general pract ices.  This procedure
lim ited the disclosure of the non- response rate, as it  is very likely that  a num ber of
non- responders have never been contacted.
I t  has been suggested that  controls taking part  in  studies tend to be m ore affluent
than  non-interviewed  cont rols  (Hepworth  et  al.,  2006b) .  A  higher  proport ion  of
cont rols (29.8% )  were categorised in the m ost  affluent  Townsend core com pared
to cases (26.9% ), part icularly for  m eningiom as (24.7% )  and acoust ic neurom as
(24,4% )  and their  health consciences may differ  from  that  of the general
populat ion (Liu et  al. ,  2001) . However, it  is unlikely to cause any bias in results.
Confounders  such  as  age  in  5-year  group,  sex,  study  region  and  deprivat ion
category  based  on  Townsend  score  (n= 5)  (Townsend  1987)  were  adjusted  for  in
our  analysis.  Exposure to pest icides and solvents m ight  be a confounder  too,  but  it
was not  adjusted for in the analysis as we did not  have data for this exposure.
I n epidemiological studies invest igat ing exposure to electrom agnetic fields as a r isk
factor  of  brain  tum ours  the  m ajor  diff iculty  is  to  obtain  an  accurate  exposure  to
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elect rom agnet ic  fields  (EMF) .  This  diff icult y  calculat ing  the  exposure  is  due  to  the
fact  that  we have not  indent ified a specific m ethod to est im ate the accurate
exposure to electrom agnetic fields.  Exposure to elect rom agnet ic f ields is com plex,
as  it  is  generated  from  several  sources,  and  st ill  it  is  not  found  an  established
m ethodology  to add-up these exposures in one total exposure (Ahlbom  et  al 2001,
WHO  –World  Health  Organizat ion  2007) .  I n  addit ion,  difficult ies  ar ise  for  the
definit ion  of  the induct ion  period  to elect rom agnet ic fields (Ahlbom  et  al  2001) .  All
t hese are obstacles to establish relevant  param eters for  the quant ificat ion of the
exposure to elect rom agnet ic fields and m ake m ore difficult  the assessm ent  of the
effects of  this exposure  to  brain  tum ours (Ahlbom  et  al  2001,  WHO –World  Health
Organizat ion 2007) .
I n  our  study  we  used  the  m ethod  of  occupat ional  calendars  with  job  t it les  for  the
collect ion  of  data.  This  m ethod  has  the  advantage  of  being  based  on  inform at ion
relat ively  easy  to obtain,  in  that  it  is possible to use secondary  data,  in  addit ion  to
being a sim ple m anner to com municate the study’s results (Ahlbom  et  al 2001) .
There is also a substant ial disadvantage to job t it les.  There is no st rong relat ion
between  the  job  t it le  and  the  workplace  elect rom agnet ic  field  (EMF)  exposure
(Kelsh  et  al  2000) .  Som e  jobs  m ight  seem  to  be  related  with  high  exposure  to
elect rom agnet ic  fields  but  actually  does  not  produce  such  exposure,  for  exam ple
the  case  of  line  engineers  who  work  m ost  of  their  t im e  in  the  office,  away  from
elect ric  facilit ies  (Floderus  1996,  Floderus  et  al  1996) .  This  m ight  be  a  reason  for
not  f inding any associat ion between exposure to elect rom agnetic fields and brain
tum ours,  as  people  who  weren’t  actually  exposed  to  elect rom agnet ic  fields  (EMF)
were classified in jobs related with high exposure.
A misclassificat ion might  occur by using Standard Indust ry Classif icat ion (SI C)  and
Standard Occupat ional Classificat ion (SOC)  codes for  the calculat ion of
elect rom agnet ic f ield exposure. Both the Standard I ndust ry Classif icat ion (SI C)  and
80
Standard Occupat ional Classificat ion (SOC)  were very broad and would include
workers  from  a  wide  range  of  workplaces,  thus  elect rom agnet ic  field  (EMF)
exposure  m ight  not  reflect  the  t rue  exposure.  The  SI C  code  system  is  used  for
classify ing  business  act iv it ies  in  the  UK,  and  it  correlates  to  and  is  developed  in
conjunct ion with t he equivalent  European Union's indust rial classificat ion system ,
NACE. NACE stands for Nom enclature Générale des Act iv ités Économ iques dans les
Com m unautés Européennes. This is French for Stat ist ical Classificat ion of Econom ic
Act ivit ies  in  the  European  Com munity.  NACE is  a  lot  easier.SI C codes  list  has  17
sect ions  and  62  divisions.  The  SOC  code  system  has  two  m ain  concepts  of
classificat ion,  kind of  work  perform ed -  job,  and the com petent  perform ance of  the
tasks  and  dut ies  –  skill.  The  SOC code  system  has  9  m ajor  groups,  25  sub  m ajor
groups,  81  m inor  groups  and  353  unit  groups.  Therefore  the  SOC code  system  is
m ore specific,  rather  the  SI C code system  which  is m ore general.  I t  m ight  be due
to  this  fact  that  we  see  such  a  difference  in  the  result s  between  exposures  to
elect rom agnet ic fields by  SI C codes and by  SOC codes.  The use of  UK SOC list ,  US
SOC  list  and  ISCO88  (a  list  m atching  the  soc  codes  for  USA  and  UK) ,  as  we
m ent ioned in  the m ethodology  sect ion,  to obtain  geom etr ic m eans of  exposure for
the missing  SOC codes it  is possible  to  has resulted  in  bias of  our  elect rom agnet ic
field  exposure  est im at ion.  Further  analysis  should  be  perform ed  using  a  job
exposure  m at rix  (a  cross  tabulat ion  table  where  rows  contain  job  t it les  ( they  can
be extended into m ore specifically  both adm inistrat ive unit s and work locat ions)
and columns contain exposure indices. Such m at rixes com prised algorithms of
lesser  or  higher  com plexity  that  m ay  take  into  account  job  t it le,  workplace,
descript ion of act ivit ies developed, ut ilizat ion of elect r ic equipm ent , and even MF
m easured by  personal dosimeters in  a sam ple of  workers.  The putat ive aet iological
t im e window per iod prior to diagnosis should also be taken into account  (Ahlbom  et
al  2001) .
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The  healthy  worker  effect  is  often  observed  in  occupat ional  studies  of  which
working populat ions have a lower overall death rate than the general populat ion,
and also ill and disabled people are excluded from em ployment  (Li & Sung, 1999) .
I t  was first  described by  William  Ogle (Ogle,  1885) ,  who observed that  the working
populat ion is healthier  than the general populat ion.  I n our study populat ion, the
healthy worker effect  (HWE)  could potent ially be a source of select ion bias (Li &
Sung, 1999;  McMichael,  1976) . Healthy indiv iduals gain em ploym ent  and rem ain in
indust ry.  I t  is likely  that  ill  or  disabled people are excluded from  em ploym ent  or  do
not  rem ain  em ployed  (Bakirci  et  al.,  2006) .  The  speculat ion  that  workers  in
indust ries with high exposures are f it t er  than people rem aining in other jobs was
m ent ioned  by  Sorahan  and  colleagues  (Sorahan  et  al.,  2001) .   Som e  cases  that
were  seriously  ill  either  did  not  want  to  part icipate  or  were  excluded  from  the
study, this could have affected the cumulat ive exposure level in our case group.
Sum m ary of discussion
Overall,  t he  study  findings  suggest  no  evidence  of  an  increased  risk  for  brain
cancer  with  elect rom agnet ic  field  (EMF)  exposure.   The  fact  that  people  in
em ploym ent  are likely t o be fit  and healthy ( the healthy worker effect )  could
int roduce select ion bias and therefore these results should be interpreted with
caut ion. We also have to consider the dif ficulty t o est im ate the t rue exposure to
elect rom agnet ic fields.  Both  the  SI C and  SOC classificat ion  include workers from  a
wide  range  of  workplaces, t hus elect rom agnetic f ield (EMF)  exposure might  not
reflect  the t rue exposure.  The fact  that  there is no st rong relat ion  between  the job
t it le  and  the workplace elect rom agnet ic field  (EMF)  exposure  should  also  be taken
into  account .  Som e  jobs  might  seem  to  be  related  with  high  exposure  to
elect rom agnet ic fields but  actually does not  produce such exposure.
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5 . Conclusion for the occupat ional e lectrom agnet ic field
exposure and the risk of bra in tum ours
This study  is a  large populat ion  based  case-cont rol  study.   I t  aim ed  to  invest igate
the  role  of  elect rom agnet ic  fields  (EMF)  and  r isk  of  developing  brain  tum ours
including its subtypes such as gliom as, m eningiom as and acoust ic neurom as.
I ndividual occupat ional EMF exposure was calculated for  all held jobs by mult iply
generic elect romagnet ic field (EMF)  geometric means derived from the Standard
I ndust ry Classificat ion (SI C)  and Standard Occupat ion Classificat ion (SOC)  with
t im e  spent  on  each  job.   The  cumulat ive  exposure  was  the  sum m at ion  of
elect romagnet ic field (EMF)  exposure from  all jobs.
The  results  showed  stat ist ically  significant  r isk  reduct ions  when  EMF  exposures
were character ised  by  the SI C Q3:  OR 0.73,  95%  CI  0.55-0.97  and  Q4:  OR 0.70,
95%  CI  0.52-0.94) .  There  is evidence of  a  decrease in  r isk  across quart iles (p  for
t rend 0.019) . Sim ilar  results were observed with gliom as (Q3:  OR 0.72, 95%  CI
0.51—1.01 and Q4:  OR 0.70, 95%  CI  0.49-0.99 -  p for  t rend 0.03) . For
m eningiom as and acoust ic neurom as, none of the results were stat ist ically
significant .  On  the  cont rary,  on  analysis  of  cumulat ive  EMF  exposure  by  the
Standard Occupat ional Classificat ion (SOC) , the protect ive effects were observed in
the 2nd and  3 rd quart ile  for  the  acoust ic  neurom a  group  only  (Q2:  crude  OR 0.56,
95%  CI  0.34-0.91, adjusted OR 0.53, 95%  CI  0.31-0.90, Q3:  crude OR 0.50, 95%
CI  0.30-0.83, adjusted OR 0.52, 95%  CI  0.29-0.93) .There was, however, no clear
t rend of r isk reduct ion for all quart iles.
These findings suggest  no evidence of an increased risk for  brain cancer with EMF
exposure.   The fact  that  people in  em ploym ent  are likely  to be fit  and healthy  ( the
healthy worker effect )  could int roduce select ion bias and therefore these results
should be interpreted with caut ion  (Li & Sung 1999, McMichael 1976, Bakirci et  al
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2006, Sorahan et  al 2001) . We also have to consider the diff iculty t o est im ate the
t rue exposure to elect rom agnet ic fields, as a specif ic m ethod to est im ate the
accurate  exposure  to  electrom agnet ic  fields  has  not  been  ident if ied  (Ahlbom  et  al
2001) .  Both  the  SI C and  SOC classificat ion  include  workers  from  a  wide  range  of
workplaces, thus elect rom agnet ic field (EMF) exposure m ight  not  reflect  the t rue
exposure. The fact  that  there is no st rong relat ion between the job t it le and the
workplace elect rom agnet ic field  (EMF)  exposure  should  also  be taken  into  account
(Kelsh  et  al  2000) .  Som e  jobs  m ight  seem  to  be  related  with  high  exposure  to
elect rom agnet ic fields but  actually does not  produce such exposure (Floderus 1996,
Floderus et  al 1996) .
The  WHO  internat ional  EMF  project  has  recom m ended  that  the  design  of
elect rom agnet ic f ield (EMF)  studies should be such as to include as much
inform at ion  relevant  to  alternat ive  m et rics  as  possible  in  order  to  aid  future
research (Word Health Organisat ion, available on ht tp: / / www.who.int / peh-
em f/ project ) . These alt ernat ive m et rics could be t im e-weighted average (TWA) ,
geom et r ic mean (GM) , interm ittency ( ITM) , m axim um  m easure (MAX) , t im e-
weighted  average  of  m easurem ents  in  harm onic  frequency  range  across  the  work
shift  (H-TWA),  and percent  of  t im e above 0.2 µT across the work  shift  (% > 0.2 µT)
(van  Tongeren  et  al  2004) .  All  t hese  m et rics  can  be  obtained  by  specific  log-
t ransform at ions.
Aim ing at  enhancing a m ore accurate quant ificat ion of occupat ional exposure we
can  invest  in  the  developm ent  of  job-exposure  m at rixes  (JEM) .  These  m at rixes
have been em ployed to assign cum ulat ive exposure to workers in several
epidem iological studies. The job-exposure m atrix  (JEM)  is a cross tabulat ion table
where rows contain  job  t it les and  colum ns contain  exposure  indices (Marcílio  et  al
2009) . I n order to assign m ore accurate and precise exposure est im ates there is a
need  these  m at rixes  to  com prised  com plex  algorithm s  that  will  t ake  into  account
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specific  job  t it le,  descript ion  of  the  tasks  each  worker  is  performing,  workplace,
accurate  t im e  of  working  and  even  direct  m easurem ents  of  exposure  with
individual dosim eters (Marcílio et  al 2009) .  Therefore, task-based quest ionnaires
should be created, in addit ion with more detailed occupat ional calendars, in order
to  assign  all  workers  within  a  job  the  r ight  m ean  of  exposure  and  avoid
m isclassificat ion  (Benke  et  al  2000,  van  Tongeren  et  al  2004) .  As  direct
m easurem ents with individual dosim eters seem  to be the preferred m ode of
assigning accurate exposure est im ates, it  is recom m ended data for all subjects in a
case-cont rol study to be obtained using this m ethod too (van Tongeren 2004) . Any
further study being conducted needs to have sufficient  power of detect ing relat ive
r isks, therefore it  is necessary to have a big sam ple size for all cases, also for the
specific subtypes of cases (gliom as, m eningiomas, acoust ic neurom as etc) , and for
cont rols (Ahlbom  et  al   2001) .  Also,  cases with  high  illness need  to  be included  in
our m easurem ents for m ore precise est im ates of the exposure, as som et im es very
ill  cases refuse or  not  be able  to  answer  the  quest ionnaire  or  accept  to  part icipate
in the direct  m easurem ents.
As exposure  to  pest icides and  solvents m ay  be a  confounder,  it  would  be bet ter  if
data for  the est im at ion  of  this exposure obtained,  with  the method of  occupat ional
calendars, and afterwards this exposure adjusted for  in the elect rom agnet ic f ield
(EMF)  analysis.  In  the  UK Adult s Brain  Tum our  Study  (UKABTS)  a  r ich  dataset  for
exposure to pest icides and solvents is available for  fur ther  invest igat ions.
Adjustm ent  for  age,  sex,  region,  and deprivat ion category  is recom mended for  any
further analysis as they are confounders too.
Overall sum m ary of the conclusion
I n conclusion, the results from  the epidem iological studies invest igat ing the
associat ion  between  elect rom agnet ic  fields  exposure  and  brain  tum ours  are
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inconsistent .  The findings of  this study  do not  support  the hypothesis that  the risk
to develop brain tum our increases with the increase of the elect rom agnet ic field
exposure. This study’s results reported inverse associat ion between
elect rom agnet ic  fields  exposure  and  the  disease.  This  is  probably  due  to  the
healthy  worker  effect  (HWE) ,  misclassificat ion  of  jobs  and  difficult ies  in  the
est im at ion  of  the  exposure.  Further  studies  m ust  be  carried  out ,  with  detailed
com plex job-exposure m atr ixes (JEMs) , bet ter classificat ion and the need to
include cases with high illness, in order to achieve m ore accurate and precise
results.
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6 . APPENDI X
6 .1  Courses, sem inars and published journals
 Postgraduate t ra ining courses at tended during the first  year
( 2 0 03 - 20 0 4  sessions) :
‚ I nt roduct ion to Faculty PG Training Program m e
‚ I nt roduct ion to Library Skills I
‚ I nt roduct ion to Library Skills I I
‚ Presentat ion Skills
‚ Tim e Managem ent
‚ Crit ical Analysis I
‚ Crit ical Analysis I I
Com m unity Health Science courses at tended dur ing the first  year
( 2 0 03 - 20 0 4 ) :
‚ Research in epidemiology with basic stat ist ics
‚ Further Quant itat ive Methods in Health Service Research
Sem inars at tended dur ing the first  year  2 0 0 3 -2 0 0 4 :
‚ I ARC I nternat ional Course on Epidemiological research in Nut r it ion and Cancer,
organized by the I nternat ional Agency for  research on Cancer ( IARC) , in Lyon,
France from  8-13 Decem ber 2003
Published papers:
‚ Dietary zinc intake and brain cancer in adults:  a case-cont rol study
Brit ish Journal of Nutr it ion (2008) , 99: 667-673 Cam bridge Universit y Press
‚ Occupat ion and exposure to elect rom agnet ic fields and the risk of brain tum ours;
a UK case cont rol study
This journal  was submit ted  to American  Journals of  Epidemiology  (AJE)  and wait s
for  publicat ion.
‚ Determ inants of occupat ional exposure to ext rem ely low frequency
elect rom agnet ic fields in the general populat ion in the UK. I n press. (2007)
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